• +91-94162-50083, 89501 91795
Facebook X-twitter Linkedin Instagram
  • info@aspopharma.com

WHO-GMP & ISO 9001: 2015 CERTIFIED

  • +91-94162-50083
  • +91-89501 91795
aspo-logo

S.No. Product Name Composition Packing Strength
1 A Balanced Protein Supplement Fortified with Essential Vitamins , Minerals & DHA Each 30g contains: Protein Hydrolysate 20% DHA 10 % Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3 Folic Acid Niacinamide Calcium (as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Magnesium Oxide Cupric Sulphate Chromium (as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride Sodium Chloride Iodine (as Potassium Iodide IP) Excipients IP IP IP IP IP USP IP USP USP IP IP 5 g 25 mg 0.5 mg 1 mcg 100 IU 0.3 mg 15 mg 200 mg 1.5 mcg 1.5 mg 10 mg 4 mg 2.5 mg 25 mcg 20 mcg 5 mg 33 mg 100 mcg q.s.
2 ABalanced Protein Supplement Fortified with Essential Vitamins & Minerals Each 30gmpowder Contains Whey Protein 30% Docosa HexaenoicAcid 10 % Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3 Folic Acid Niacinamide Calcium (as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Magnesium Oxide Cupric Sulphate Chromium (as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride Sodium Chloride Iodine (as Potassium Iodide IP) Excipients IP IP IP IP IP USP IP USP USP IP IP 10 g 25 mg 0.5 mg 1 mcg 100 IU 300 mcg 15 mg 200 mg 1.5 mcg 1.5 mg 10 mg 4 mg 2.5 mg 25 mcg 20 mcg 5 mg 33 mg 100 mcg q.s.
3 Acebrophylline , Terbutaline Sulphate & Guaiphenesin Syrup Each 5ml contains : Acebrophylline Terbutaline Sulphate Guaiphenesin In a flavoured Syrupybase. Approved Colour Used. IP IP 50mg 1.25 50mg q.s.
4 Acebrophylline & Acetylcysteine Tablets Each film coated Tablet Contains: Acebrophylline Acetylcysteine Excipients Approved colour used. BP 100mg 600mg q.s.
5 Acebrophylline & N- Acetyl L- Cysteine Tablets Each film coatedBilayered Tablet Contains: Acebrophylline N- Acetyl L-Cysteine Excipients Approved colour used BP 100mg 600mg q.s.
6 Acebrophylline & N- Acetyl L- Cysteine Tablets Each film coated Tablet Contains: Acebrophylline N- Acetyl L-Cysteine Excipients Approved colour used BP 100mg 600mg q.s.
7 Acebrophylline Capsule Each hardgelatin capsule contain: Acebrophylline Excipients Approved colour used in emptycapsule shell 100 mg q.s
8 Acebrophylline Sustained Release Tablets Each film coated sustained release Tablet contains : Acebrophylline Excipients Approved colour used 200mg q.s.
9 Acebrophylline Sustained Release Tablets Each film coated sustained release Tablet contains : Acebrophylline Excipients Approved colour used 200mg q.s.
10 Aceclofenac & DrotaverineTablets Each FilmCoated Tablet Contains: Aceclofenac Drotaverine Hydrochloride Excipients Colour : ApprovedColour Used IP IP 100mg 80mg q.s.
11 Aceclofenac & Paracetamol Suspension Each 5ml contains: Aceclofenac Paracetamol In a Flavoured SyrupyBase. Approved colour used IP IP 100mg 250mg q.s.
12 Aceclofenac & Paracetamol Tablets Each Uncoated Tablets Contains: Aceclofenac Paracetamol Excipients Approved colour used IP IP 100 mg 325 mg q.s.
13 Aceclofenac & Serratiopeptidase Tablets Each film coated Tablet Contains: Aceclofenac Serratiopeptidase (Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved colour used. IP IP 100mg 15mg q.s.
14 Aceclofenac & Serratiopeptidase Tablets Each filmcoated tablet contain: Aceclofenac Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved colour used IP IP 100 mg 10 mg q.s.
15 Aceclofenac & Thiocolchicoside Tablets Each FilmCoated Tablet Contains: Aceclofenac Thiocolchicoside Excipients Colour : ApprovedColour Used IP IP 100mg 4mg q.s.
16 Aceclofenac & Thiocolchicoside Tablets Each FilmCoated Tablet Contains: Aceclofenac Thiocolchicoside Excipients Colour : ApprovedColour Used IP IP 100mg 8mg q.s.
17 Aceclofenac along with Linseed oil, Menthol, Methyl Salicylate & Capsaicin Composition :- Aceclofenac Linseed Oil Menthol Methyl Salicyclate Capsaicin Banzyl Alcohol (as Preservative) Gel base IP BP IP IP USP IP 1.5%w/w 3%w/w 5%w/w 10%w/w 0.010%w/w 1%w/w q.s.
18 Aceclofenac Sustained Release Tablets Each FilmCoatedTablet Contains: Aceclofenac (AsSustained Release) Excipients Colour : ApprovedColour Used IP 200mg q.s.
19 Aceclofenac Tablets Each film coated Tablets Contains : Aceclofenac Excipients Approved colour used. IP 100mg q.s.
20 Aceclofenac, Paracetamol & Chlorzoxazone Tablet Each FilmCoatedTablet Contains Aceclofenac Paracetamol Chlorzoxazone Excipients Approved colour used IP IP USP q.s. 100 mg 325 mg 250 mg
21 Aceclofenac, Paracetamol & Chlorzoxazone Tablets Each Film coated Tablet Contains: Aceclofenac Paracetamol Chlorzoxazone Excipients Approved colour used IP IP USP 100mg 325mg 500mg q.s.
22 Aceclofenac, Paracetamol & Chymotrypsin Tablets Each Film coatedTabletsContains: Aceclofenac Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymaticactivity (Supplied bya purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients Approved colour used IP IP 100 mg 325 mg 50000AU q.s.
23 Aceclofenac, Paracetamol & Serratiopeptidase Tablets Each film coatedTablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. toenzyme activityof 30000 units of enteric coated granules) Excipients Approved Colour Used IP IP IP 100mg 325mg 15mg q.s.
24 Aceclofenac, Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. to 20,000 Serratiopeptidase units) Excipients Approved Colour Used. IP IP IP 100mg 325mg 10mg q.s.
25 Aceclofenac, Paracetamol & Thiocolchicoside Tablet Each FilmCoatedTablet Contains Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used IP IP q.s. 100 mg 325 mg 4 mg
26 Aceclofenac, Paracetamol & Thiocolchicoside Tablet Each Film Coated Tablet Contains Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used IP IP q.s. 100 mg 325 mg 8 mg q.s.
27 Aceclofenac, Paracetamol Tablets Each FilmcoatedTabletsContains: Aceclofenac Paracetamol Excipients Approved colour used IP IP 100 mg 325 mg q.s.
28 Aceclofenac,Par acetamol, Phenylephrine HCL,Cetirizine HCL&Caffeine Tablets Each uncoated tablet contains: Aceclofenac Paracetamol Phenylephrine HCL Cetirizine HCL Caffeine Anhydrous IP IP IP IP IP 100mg 325mg 10mg 5mg 25mg q.s.
29 Aceclofenac,Paracetamol, Caffeine, Phenylephrine HCL& Cetirizine Hydrochloride Tablets Each uncoated tablet contains: Aceclofenac Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Caffeine (Anhydrous) Excipients Approved colour used IP IP IP IP IP 100 mg 325 mg 5 mg 10 mg 25 mg q.s.
30 Acetaminophen, Dextromethorphan, Guaiphenesin, Phenylephrine HCl, Chlorpheniramine Maleate & Menthol Suspension Each 5ml Contains : Acetaminophen Dextromethorphan Hydrobromide Guaiphenesin Phenylephrine Hydrochloride Chlorpheniramine Maleate Menthol In a flavoured Suspension Base Colour: Sunset Yellow FCF USP BP BP BP BP BP 250mg 10mg 50mg 5mg 2mg 1mg q.s
31 Acetonide Cream Fluocinolone Acetonide In a cream Base IP 0.1 mg q.s.
32 Aciclovir Cream IP Composition :- Aciclovir In a cream Base IP 5%w/w q.s.
33 Aciclovir Dispersible Tablet IP Each uncoated tablet contains: Aciclovir Excipients Approved colour used IP 800 mg
34 Aciclovir Tablet IP Each uncoated tablet contain: Aciclovir Excipients Approved colour used IP 800 mg q.s.
35 Acyclovir Dispersible Tablets IP Each uncoatedTabletsContains: Acyclovir Excipients Approved colour used IP 400 mg q.s.
36 Albendazole & Ivermectin suspension Each 5 ml contains: Albendazole Ivermectin Flavoured syrupybase IP IP 200 mg 1.5 mg
37 Albendazole & Ivermectin Tablet Each Uncoated tablet contains: Albendazole Ivermectin Excipients Colour :-Approved colour used IP IP 400mg 6mg q.s.
38 Albendazole Oral Suspension IP Each ml Contains: Albendazole In flavoured Syrupybase Approved colour used IP 200 mg q.s.
39 Albendazole Oral Suspension IP Each 5ml contains: Albendazole Excipients Approved colour used IP 200mg q.s.
40 Albendazole Tablet IP Each Uncoated Chewable Tablet Contains:- Albendazole Excipients Colour:-Approved Colour used IP 400mg q.s.
41 Allopurinol Tablets IP Each uncoated tablets contains: Allopurinol Excipients Approved colour used IP 100 mg q.s.
42 Allopurinol Tablets IP Each uncoated tablets contains: Allopurinol Excipients Approved colour used IP 300 mg q.s.
43 Alpha LipoicAcid, Benfotiamine , Multivitamin & Multimineral Capsules Each Hard Gelatin CapsuleContains: Mecobalamin Alpha LipoicAcid Benfotiamine Vitamin B6 Calcium Pantothenate Folic Acid Zinc Oxide Chromium Picolinate Inositol Lutein Excipients Approved Colour used. IP USP IP IP IP IP USP USP USP 1500mcg 100mg 15mg 3mg 25mg 1.5mg 22.5mg 65mcg 10mcg 5mg q.s.
44 Alpha-Amylase & Papain Syrup Each 5ml contains: Alpha-Amylase (Bacterial 1:800) Papain In a flavoured non-syrupy base Approved colour used. I.P. I.P. 100mg 50mg q.s.
45 Alprazolam Tablets IP Each uncoated tablet contains: Alprazolam Excipients Approved colour used IP 0.25 mg q.s
46 Alprazolam Tablets IP Each uncoated tablet contains: Alprazolam Excipients Approved colour used IP 0.5 mg q.s
47 Aluminium , Magnesium & simethicone oral Suspension IP Each 10ml contains : Aluminiumhydroxide Gel Equ. to Dried Aluminium Hydroxide Gel Magnesium Hydroxide Paste Equ. to Magnesium Hydroxide Simethicone In a flavoured Palatable Base Colour :Erythrosine & Tartrazine IP IP IP 250mg 250mg 50mg q.s
48 Aluminium Hydroxide, Magnesium Hydroxide & Oxetacaine Oral Suspension Each 5 ml contains: Aluminium Hydroxide (Added Aluminium Hydroxide paste Eq. to dried aluminium hydroxide gel ) Magnesium Hydroxide (Added as magnesium Hydroxide Paste) Oxetacaine Flavoured palatable base IP IP IP BP 0.291 g 0.380 g 98 mg 10 mg q.s.
49 Ambroxal Hydrochloride Drops Each ml contains: Ambroxal Hydrochloride In a flavoured base Approved colour used IP 7.5mg q.s.
50 Ambroxal Hydrochloride Syrup Each 5ml contains: Ambroxal Hydrochloride In a flavoured base Approved colour used IP 30mg q.s.
51 Ambroxol HCl , Terbutaline Sulphate, Guaiphenesin and Menthol Syrup Each 5ml contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a flavoured syrupybase. Approved colour used. IP IP IP IP 15mg 1.5mg 50mg 2.5mg q.s.
52 Ambroxol HCL, Cetirizine HCL, Phenylephrine HCL, Guaiphenesin & Menthol Syrup Each 5ml Contains: Ambroxol Hydrochloride Cetirizine Hydrochloride Phenylephrine Hydrochloride Guaiphenesin Menthol In flavoured Palatable base Approved colour used IP IP IP IP IP 4 mg 2.5 mg 5 mg 50 mg 1 mg q.s.
53 Ambroxol HCl, Levosalbutamol & Guaiphenesin Drops Each ml Contains : Ambroxol Hydrochloride Levosalbutamol Sulphate Equ. to Levosalbutamol Guaiphenesin In a Flavoured SyrupyBase Colour : Ponceau 4R IP IP IP 7.5mg 0.25mg 12.5 mg q.s
54 Ambroxol Hcl, Levosalbutamol & Guaiphenesin Syrup Each 5ml Contains : Ambroxol Hydrochloride Levosalbutamol Sulphate Equ. to Levosalbutamol Guaiphenesin In a Flavoured SyrupyBase Colour : Ponceau 4R IP IP IP 15mg 0.5mg 50mg q.s
55 Ambroxol HCL, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Each 5ml contains: Ambroxol HCL Terbutaline Sulphate Guaiphenesin Menthol In a flavoured sugar free base IP IP IP IP 15mg 1.25mg 50mg 1mg q.s.
56 Ambroxol Hydrochloride , Phenylephrine Hydrochloride ,Chlorpheniramine Maleate, Guaiphenesin & Menthol Syrup Each 5ml. contains : Phenylephrine HCL Ambroxol Hydrochloride Guaiphenesin Chlorpheniramine Maleate Menthol In a Flavoured syrupybase Approved colour used. IP IP IP IP IP 5mg 15mg 50mg 2mg 1.5mg q.s.
57 Ambroxol Hydrochloride (SR)& Levocetirizine hydrochloride Tablets Each Filmcoated Tablet Contains:- Ambroxol Hydrochloride (As sustained Release) Levocetirizinehydrochloride Excipients Approved colour used P IP 75 mg 5mg q.s.
58 Ambroxol Hydrochloride & Cetirizine Hydrochloride Syrup Each 5ml contains : Ambroxol Hydrochloride Cetirizine Hydrochloride In a Flavoured SyrupyBase. Approved colour used IP IP 30mg 5mg q.s.
59 Ambroxol Hydrochloride Syrup Each 5ml contains : Ambroxol Hydrochloride In a Flavoured SyrupyBase Approved colour used IP 30mg q.s.
60 Ambroxol Hydrochloride Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Each 5ml. contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a Sorbitol Solution (70%) (Non-Crystallising) Approved colour used IP IP IP IP 15mg 1.25mg 50mg 2.5mg q.s.
61 Ambroxol Hydrochloride, Levosalbutamol Sulphate & Guaiphenesin Syrup Each 5ml Contains Ambroxol Hydrochloride Levosalbutamol Sulphate Eq. to Levosalbutamol Guaiphenesin In flavoured Syrupybase Approved colour used IP IP IP 30 mg 1 mg 50mg q.s.
62 Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin oral Drops Each ml(Approx. 20drops) contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin In a flavoured syrupyBase. Approved colour used. IP IP IP 7.5mg 0.5mg 12.5mg q.s.
63 Ambroxol Terbutaline Guaiphenesin with Menthol Syrup Each 5ml Contains :- Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In flavoured syrupyBase Approved Colour Used. IP IP IP IP 15mg 1.25mg 50mg 2.5mg q.s.
64 Ambroxol Terbutaline Guaiphenesin with Menthol Syrup Each 5ml Contains :- Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In flavoured syrupyBase Approved Colour Used. IP IP IP IP 30mg 2.5mg 100mg 2.5mg q.s.
65 Amisulpride Tablets IP Each Uncoated Tablet Contains: Amisulpride Excipients Approved colour used. IP 100mg q.s.
66 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used IP 10 mg q.s
67 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used IP 25 mg q.s.
68 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used IP 50 mg q.s.
69 Amlodipine & AtenololTablets Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Atenolol Excipients Colour:-Approved colour used IP IP 5 mg 50 mg q.s.
70 Amlodipine Tablets IP Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients Colour : Approved Coloured Used IP 5 mg q.s
71 AmlodipineTablets IP Each uncoated Tablet contains: Amlodipine Besylate Equ. to Amlodipine Excipients Approved colour used IP 2.5mg q.s.
72 AmlodipineTablets IP Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients Colour : Approved Coloured Used IP 10 mg q.s
73 Amorolfine Cream 0.25% w/w Composition : Amorolfine Hydrochloride Equ. to Amorolfine Excipients Cream Base IP 0.25%w/w q.s.
74 Artemether & Lumifantrine Tablets Each uncoatedTabletsContains: Artemether Lumifantrine Excipients Approved colour used IP 80 mg 480 mg q.s.
75 Ascorbic Acid (Vitamin C ), Sodium Ascorbate & Zinc Chewable Tablets Each uncoated Tablet Contains: Ascorbic Acid Sodium Ascorbate Equ. to Ascorbicacid Zinc Excipients Approved Colour Used IP IP 100mg 450mg 400mg 5mg q.s
76 Ascorbicacid Tablet IP Each Uncoated ChewableTablet Contains Ascorbic acid Excipients Colour : ApprovedColour Used IP 500mg
77 Atenolol Tablets IP Each Uncoated Tablet Contains: Atenolol Excipients Colour : Approved Coloured Used IP 50mg q.s
78 Atenolol Tablets IP Each Uncoated Tablet Contains: Atenolol Excipients Colour : Approved Coloured Used IP 100mg q.s
79 Atorvastatin & FinofibrateTablets Each filmcoated tablet contain Atorvastin Calcium Eq.to Atorvastin Finofibrate Excipients Approved colour used IP IP 10 mg 160 mg q.s.
80 Atorvastatin and Aspirin Capsules Each hard gelatin capsule contains: Atorvastatin Calcium Equ. to Atorvastatin (In IRPellets form) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells. IP IP 10mg 75mg
81 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used IP 10 mg q.s.
82 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used IP 20 mg q.s.
83 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used IP 40 mg q.s.
84 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used IP 80 mg q.s.
85 Atorvastatin, Clopidogrel and Aspirin Capsules Each hard gelatin capsule contains: Atorvastatin Calcium Equ. to Atorvastatin (as Pellets) Clopidogrel Bisulphate Equ. to Clopidogrel ( as Pellets) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells. IP IP IP 20mg 75mg 75mg
86 Azathioprine Tablets IP Each uncoated tablet contains: Azathioprine Excipients Approved colour used. IP 50mg q.s.
87 Azithromycin & Lacticacid Bacillus Tablet Each film coated tablet contains: Azithromycin Dihydrate Equ. toAzithromycin Anhydrous Lactic acid Bacillus Excipients Approved colour used IP 250mg 60 million spores q.s
88 Azithromycin & Lacticacid Bacillus Tablet Each film coated tablet contains: Azithromycin Dihydrate Equ. toAzithromycin Anhydrous Lactic acid Bacillus Excipients Approved colour used IP 500mg 60 million spores q.s
89 Azithromycin Dispersible Tablet Each uncoated dispersible Tablet Contains : Azithromycin Dihydrate Equ. to Azithromycin anhydrous Excipients Colour : Approved Coloured Used IP 100mg
90 Azithromycin Oral Suspension IP Each 5 ml contains Azithromycin Dihydrate eq. toAnhydrousAzithromycin In a flavoured Syrupybase. Approved Colour Used IP 200mg q.s.
91 Azithromycin Suspension IP Each 5 ml contain: Azithromycin Dihydrate Equivalent to Azithromycin Anhydrous In flavoured Syrupybase Approved colour used IP 100 mg q.s
92 Azithromycin Tablet IP Each film coated tablet contains: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Excipients Approved colour used IP 250 mg q.s.
93 Azithromycin Tablet IP Each film coated tablet contains: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Excipients Approved colour used IP 500 mg q.s.
94 B –Complex Capsules Each hard gelatin capsule contains Vitamin B1 (Thiamine Mononitrate) Vitamin B2 (Riboflavin) Vitamin B6 (Pyridoxine Hydrochloride) Niacin (Nicotinamide) Pantothenic Acid (Calcium D-Pantothenate) Vitamin B12 (Cyanocobalamin) Folic Acid (n-pteroyl L-Glutamic Acid) Zinc (as Zinc Sulphate) Bacillus Coagulans Biotin (D-Biotin) Excipients Approved colour used in emptycapsule shells. IP IP IP IP IP IP IP IP IP 1.1mg 1.3mg 2mg 14mg 5mg 1mcg 100mcg 10mg 2000 Millions 30mcg q.s
95 B- Complex Capsules Each hard gelatin capsule contains Thiamine Mononitrate Riboflavin Sodium Phosphate Pyridoxine Hydrochloride Niacinamide Calcium Pantothenate Vitamin B12 Folic Acid Biotin Ascorbicacid Excipients Approved colour used in emptycapsule shells. IP IP IP IP IP IP IP USP IP 10mg 10mg 3mg 100mg 50mg 15mcg 1.5 mg 100mcg 150mg q.s
96 B-complex with L- Lysine Capsules Each hard gelatin capsule contains Thiamine Mononitrate Riboflavin Sodium Phosphate Pyridoxine Hydrochloride Niacinamide Calcium Pantothenate Vitamin B12 Folic Acid L-Lysine Mono Hydrochloride Excipients Approved colour used in emptycapsule shells. IP IP IP IP IP IP IP USP 10mg 10mg 3mg 50mg 20mg 5mcg 1000mcg 150mg q.s
97 B-Complex with L- Lysine Syrup Each 5ml contains : L-Lysine Monohydrochloride Vitamin B1 Vitamin B2 Vitamin B6 Methylcobalamin Niacinamide Zinc Sulphate Ina pleasantlySyrupyBase Colour : Tartrazine FCF USP IP IP IP IP IP IP 25mg 1.5mg 1.0mg 0.5mg 2mcg 15mg 2.0mg q.s
98 B-Complex with Lysine Syrup Each 5ml contains :- Lysine Hydrochloride Pyridoxinehydrochloride Niacinamide Cyanocobalamin D- Panthenol Zinc SulphateMonohydrate Equ. toElemental zinc In flavored syrupybase ApprovedColour Used USP IP IP IP IP IP 200mg 1.5mg 25mg 7.5mcg 5mg 16.5mg q.s.
99 Baclofen Tablets IP Each uncoated tablet contains: Baclofen Excipients Approved colour used. IP 10mg q.s.
100 Baclofen Tablets IP Each uncoated tablet contains:- Baclofen Excipients Approved colour used. IP 25mg q.s
101 Baclomethasone Dipropionate, Neomycin and Clotrimazole Cream Composition Baclomethasone Dipropionate Neomycin sulphate Clotrimazole In cream base strength 0.025 %w/w 0.5 % w/w 1 % w/w q.s.
102 Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride Cream Composition: Beclomethasone Dipropionate Phenylephrine Hydrochloride Lignocaine Hydrochloride Preservative Chlorocresole Aqueous cream base IP IP IP IP 0.025%w/w 0.10% w/w 2.50% w/w 0.1% w/w q.s.
103 Benfotiamine Mecobalamin , Alpha Lipoic acid, Inositol , Pyridoxine Hydrochloride & Folicacid Capsules Each hard gelatin capsule contains Benfotiamine Mecobalamin Alpha Lipoic acid , Inositol , Pyridoxine Hydrochloride Folic acid Excipients Approved colour used in emptycapsule shells. IP IP USP IP IP IP 100mg 1000mcg 200mg 100mg 3mg 1.5mg q.s
104 Betahistine Tablet (SR) IP Each uncoated sustainedrelease tablet contain: Betahistine Hydrochloride Excipients Approved colour used IP 24 mg q.s.
105 Betahistine Tablet IP Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients Approved colour used IP 8mg q.s
106 Betahistine Tablet IP Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients Approved colour used IP 16 mg q.s.
107 Betahistine Tablets IP Each uncoated Tablet contains: Betahistine Hydrochloride Excipients Approved colour used. IP 24mg q.s.
108 Betahistine Tablets IP Each uncoated tablets contains: Betahistine Hydrochloride Excipients Approved colour used IP 8 mg q.s.
109 Betahistine Tablets IP Each uncoated tablets contains: Betahistine Hydrochloride Excipients Approved colour used IP 16 mg q.s.
110 Betamethasone Tablets IP Each uncoated tablet contains:- Betamethasone Excipients Colour : Approved Coloured Used IP 0.5mg q.s.
111 Bilastine & Montelukast Tablets Each Film Coated bilayered tablet Contains: Montelukast Sodium eq. to Montelukast Bilastine Excipients Approved colour used. IP 10mg 20mg q.s.
112 Bilastine Tablets Each Film Coated Tablet Contains: Bilastine Excipients Approved colour used 20mg q.s.
113 Biotin & FolicAcid Tablets Each film coated Tablet contains: Biotin Folic Acid Excipients Approved Colour used USP IP 5mg 5mg q.s
114 Biotin Tablets USP Each Film coated Tablet Contains : Biotin Excipients Approved colour used USP 10mg q.s.
115 Bisacodyl Tablets IP Each enteric coated tablet contains: Bisacodyl Excipients Approved colour used IP 5mg q.s.
116 Bisoprolol Fumarate Tablets Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved colour used. IP 2.5mg q.s.
117 Bisoprolol Fumerate Tablets Each film coated tablet contains: Bisoprolol Fumerate Excipients Approved colour used. IP 5mg q.s.
118 Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin &Menthol Syrup Each 5ml contains : Bromhexine Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a flavoured SyrupyBase. Approved colour used. IP IP IP IP 4mg 1.25mg 50mg 2.5mg q.s
119 Calamine & Liquid Paraffin Lotion Composition : Calamine Liquid Paraffin Lotion Base IP IP 8.0%w/w 10%w/w q.s.
120 Calcitriol & Calcium Citrate Suspension Each 5ml contains: Calcitriol Calcium Citrate Equ. To Elemental CalciumIn a Flavoured syrupyBase.Approved colour used. IP USP 0.0625mcg 100mg q.s.
121 Calcium Carbonate & Vitamin D3 Tablets Each film coated Tablet contains: Calcium Carbonate (Derived from an organic source oyster shell) Equ. to Elemental Calcium Vitamin D3 Excipients Approved colour used IP IP 1250mg 500mg 500IU q.s.
122 Calcium Carbonate, & Vitamin D3 Suspension Each 5ml Contains : Calcium Carbonate 625mg (Derived from Oyster Shell) Equ. to elemental Calcium Vitamin D3 Flavoured SyrupyBase ApprovedColour Used IP IP 250mg 125IU q.s.
123 Calcium Carbonate, Magnesium Hydroxide, Zinc & Vitamin D3 Suspension Each 5ml contains: Calcium Carbonate Eq. toElementalCalcium Magnesium Hydroxide Eq. toElemental Magnesium Zinc Gluconate Eq. toElemental zinc Vitamin D3 In a Flavoured syrupybase Approved colour used IP IP USP IP 625 mg 250 mg 180 mg 75 mg 14 mg 2 mg 200 IU
124 Calcium Carbonate, Vitamin d3 Magnesium& Zinc Suspension. Each 5ml contains: Calciumcarbonate (eq. toElemental calcium150mg) Vitamin D3 Magnesium Hydroxide (Eq.to Elemental magnesium) Zinc Gluconate Eq.to Elemental zinc In flavored syrupybase ApprovedColour Used IP IP IP IP 375mg 200IU 25mg 10.45mg 1.5mg q.s.
125 Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets Each Film Coated Tablet Contains : Calcium Carbonate( from Oyster shell) Equ. to Elemental Calcium Vitamin D3 Methylcobalamin L- Methylfolate Calcium Pyridoxal-5- Phosphate Excipients Approved colour used. IP IP 1250mg 500mg 2000IU 1500mcg 1mg 20mg q.s.
126 Calcium Citrate Maleate, Calcitriol , Folic Acid , Zinc & Vitamin K2-7 Tablets Each Film Coated Tablet Contains: Calcium Citrate Maleate Equ. toElemental Calcium Calcitriol Folic Acid Zinc Sulphate Monohydrate Equ. to Zinc Vitamin K2-7 Excipients Approved colour used IP IP IP 250mg 0.25mcg 100mcg 7.5mg 50mcg q.s.
127 Calcium Citrate Maleate, Methylcobalamin, Vitamin D3, Vitamin K2-7, Magnesium Oxide & Zinc Oxide Tablets Each film coated tablet contains: Calcium Citrate Maleate Methylcobalamin Vitamin D3 Vitamin k2-7 Zinc Oxide Magnesium Oxide Excipients Approved colour used IP IP IP IP 1250mg 1500mcg 1000IU 90mcg 15mg 50mg q.s.
128 Calcium Citrate Maleate& Vitamin D3 Tablets Each film coated Tablet Contains: Calcium Citrate Maleate Equ.ToElemental CalciumVitamin D3 Excipients Approved colour used USP IP 1250mg 250mg 450IU q.s.
129 Calcium Citrate, Calcitriol , Zinc & Manganese Tablets Each film coated tablet contains: Calcium Citrate Calcitriol Zinc Sulphate Monohydrate Eq. to elemental Zinc Manganese (as Manganese Sulphate) Excipients Approved colour used. USP BP IP IP 1000 mg 0.25 mcg 7.5 mg 40 mg q.s.
130 Calcium Citrate, Magnesium, Zinc With Vitamin D3 Tablets Each film coatedTablet Contains: Calcium Citrate Magnesium Hydroxide Zinc SulphateMonohydrate Equ. to Elemental Zinc Vitamin D3 Excipients Approved Colour Used. USP IP IP IP 1000mg 100mg 4mg 200IU q.s.
131 Calcium Orotate & Vitamin D3 Tablets Each film coated tablet contains: Calcium Orotate Vitamin D3 (Stabilized) Excipients Approved colour used. Appropriate overages of vitamin added to compensate the loss on storage. I.P. 740mg 1000 IU q.s.
132 Calcium Pantothenate Tablets I.P. 200mg Each film coated tablet contains: D-Calcium Pantothenate Excipients Approved colour used. I.P. 200mg q.s.
133 Calcium Phosphorus, Magnesium, Zinc& Vitamin D3 Suspension Each 10ml (2Teaspoonful) Contains: Calcium Phosphate Equ. To Elemental Calcium Equ. ToElemental PhosphorusMagnesium Hydroxide Equ. ToElemental MagnesiumZinc Gluconate Equ. ToElemental ZincVitamin D3 In a Flavoured Palatable Base Approved colour used. IP IP USP IP 300mg 150mg 75mg 4mg 400IU q.s.
134 Calcium, Vitamin D3, Vitamin B12 & Lysine Hydrochloride Suspension Each 5ml contains: Calciumcarbonate Equ. toElemental Calcium Vitamin D3 Vitamin B12 Lysine Hydrochloride Flavoured sorbitol base. Approved colour used. IP IP IP USP 150mg 200IU 2.5mcg 25mg q.s.
135 Calcium,Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets Each film coated tablet contains: Calcium Carbonate eq.to Elemental Calcium Vitamin D3 Mecobalamin (Methylcobalamin) L-Methylfolate calcium Pyridoxal-5-Phosphate Excipients Approved colour used. IP IP IP 1250mg 500mg 2000 I.U. 1500mcg 1mg 20mg q.s.
136 Calcium&Vitamin D3 Tablets IP Each Film coated Tablet Contains: Calcium Carbonate Equ.toElemental Calcium Vitamin D3 Excipients Approved Colour Used. IP IP 500mg 250IU q.s.
137 Carbamazepine Tablets IP Each uncoated tablet contains:- Carbamazepine Excipients Colour:- Approved Colour used IP 200 mg q.s.
138 Carbimazole Tablets IP Each Film coated Tablet Contains : Carbimazole Excipients Approved colour used IP 5mg q.s.
139 Carbonyl Iron, folic acid, Vitamin B12 and Zinc Sulphate Capsules Each hardgelatin capsule contain: Carbonyl Iron Equivalent toElemental Iron Folic acid Vitamin B12 Zinc sulphate monohydrate Equivalent to elemental zinc Excipients Approved colour used in emptycapsule shells IP IP IP 100 mg 1.5 mg 15mcg 22.5 mg q .s.
140 Carisoprodol Tablets IP Each Uncoated tablet contains:- Carisoprodol Excipients Colour:- Approved Colour used IP 350 mg q.s
141 Carvedilol Tablets IP Each Uncoated Tablet contains: Carvedilol Excipients Approved colour used IP 3.125mg q.s.
142 Carvedilol Tablets IP Each uncoated Tablet Contains: Carvedilol Excipients Approved colour used IP 12.5mg q.s.
143 Carvedilol Tablets IP Each Uncoated Tablet contains: Carvedilol Excipients Approved colour used IP 6.25mg q.s.
144 Carvedilol Tablets IP Each film coated Tablet contains: Carvedilol Excipients Approved colour used IP 3.125mg q.s.
145 Celecoxib Capsules Each hard gelatin capsules contains: Celecoxib Excipients Approved colour used in emptycapsule shell. IP 200mg q.s.
146 Cetirizine Dihydrochloride, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride Syrup Each 5ml contains : Dextromethorphan Hydrobromide Cetirizine Dihydrochloride Phenylephrine Hydrochloride In a flavoured SyrupyBase Approved colour Used IP IP IP 10mg 5mg 5mg q.s.
147 Cetirizine HCl, Phenylephrine HCl & Paracetamol Tablets Each film coated tablet contains: Cetirizine HCl Phenylephrine HCl Paracetamol Excipients Approved colour used. (Banned drug 12/08/2024) IP IP IP 5mg 5mg 325mg q.s.
148 Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets Each film coated tablet contains: Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used. I.P. I.P. 5mg 60mg q.s.
149 Cetirizine Hydrochloride Syrup IP Each 5 ml contains: Cetirizine Hydrochloride In a flavoured syrupybase Approved colour base IP 5 mg q.s.
150 Cetirizine Hydrochloride Tablets IP Each uncoated tablet contains:- Cetirizine Hydrochloride Excipients Colour:- Approved Colour used IP 10 mg q.s.
151 Chlordiazepoxide & Clidinium Bromide Tablet Each FilmCoated tablet contains Chlordiazepoxide Clidinium Bromide Excipients Approved Colour used IP IP 5mg 2.5mg q.s
152 Chlorhexidine Gluconate, Metronidazole & Lignocaine Hydrochloride Gel Composition :- Chlorhexidine Gluconate Solution Equ. to Chlorhexidine Metronidazole Equ. to Metronidazole Lignocaine Hydrochloride Gel Base IP IP IP 1%w/w 1%w/w 2%w/w q.s.
153 Chlorhexidine Gluconate, Sodium Fluoride & Zinc Chloride Mouthwash Composition : Chlorhexidine Gluconate (as Chlorhexidine Gluconate Solution IP) Sodium Fluoride ZincChloride Base Colour: Brilliant Blue FCF IP IP 0.2%w/v 0.05%w/v 0.09%w/v q.s
154 Chlorhexidine GluconateSolution & Cetrimide Antiseptic Liquid Composition: ChlorhexidineGluconate solution Cetrimide Solution Base IP IP 0.3% v/v 0.6% w/v q.s.
155 Chlorhexidine mouth wash IP Chlorhexidine Gluconate Solution diluted to Chlorhexidine Gluconate In a flavoured Aqueous base Approved colour used. IP 0.2% w/v q.s.
156 Chlorpheniramine Maleate tablet IP Each Uncoated Tablet Contains: Chlorpheniramine Maleate Equ. to Chlorpheniramine Excipients IP 4mg q.s.
157 Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Dextromethorphan Hydrobromide Syrup Each 5ml contains : Chlorpheniramine Maleate Phenylephrine Hydrochloride Dextromethorphan Hydrobromide In a flavoured palatable base Approved colour used. IP IP IP 2mg 5mg 15mg q.s.
158 Chlorpromazine Hydrochloride Tablets IP Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients Colour:- Approved Colour used IP 50 mg q.s.
159 Chlorpromazine Hydrochloride Tablets IP Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients Colour:- Approved Colour used IP 100 mg q.s.
160 Chlorpromazine Hydrochloride Tablets IP Each film coated Tablet Contains: Chlorpromazine Hydrochloride Excipients Approved colour used. IP 50mg q.s.
161 Chlorzoxazone, Diclofenac Potassium, Paracetamol Each film coated tablet contains: Chlorzoxazone Diclofenac Potassium Paracetamol Excipients Approved colour used. USP BP IP 250mg 50mg 325mg q.s.
162 Cholecalciferol GranulesSachet Each sachet of1gmContains: Cholecalciferol Excipients IP 60000 IU q.s
163 Cholecalciferol oral solution USP Each ml Contains: Cholecalciferol (Vitamin D3) In a pleasantlyflavoured palatable Base Approved Colour used. IP 400IU q.s.
164 Cholecalciferol Tablet IP Each uncoated chewable tablet contains Cholecalciferol (Stabilized) Excipients Colour :- Approved colour used IP 60000IU q.s.
165 Cholecalciferol, Ferrous Ascorbate, Folic Acid & Cyanocobalamin Tablets Each film coated Tablet Contains: Cholecalciferol Ferrous Ascorbate Equ. toElemental Iron Folic Acid Cyanocobalamin Excipients Approved colour used IP IP IP 1000IU 100mg 1mg 7.5mcg q.s.
166 Choline Salicylate & Lignocaine Hydrochloride Gel Composition : Choline Salicylate Solution Equ. to Choline Salicylate Lignocaine Hydrochloride Preservative: Benzalkonium Chloride In Pleasant Flavoured Base BP IP IP 8.7%w/w 2.0%w/w 0.01%w/w q.s
167 Choline Salicylate, Lignocaine Hydrochloride and Benzalkonium Chloride Gel Composition : Choline Salicylate Solution Equ. to Choline Salicylate Lignocaine Hydrochloride Benzalkonium Chloride In a Flavoured Mucoadhesive gel base BP IP IP 8.7%w/w 2.0%w/w 0.01%w/w q.s
168 Cilnidipine Tablet Each film coated tablet contains Cilnidipine Excipients Colour :- Approved Colour Use IP 10mg q.s
169 Cilnidipine Tablets IP Each film coated tablet contains: Cilnidipine Excipients Approved colour used. IP 5mg q.s.
170 Cilnidipine Tablets IP Each film coated tablet contains: Cilnidipine Excipients Approved colour used. IP 5mg q.s.
171 CilnidipineTablets IP Each film coated Tablet contains: Cilnidipine Excipients Approved colour used. IP 20mg q.s.
172 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved colour used. IP 50mg q.s.
173 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved colour used. IP 100mg q.s.
174 Cinnarizine (SR)Tablet IP Each uncoatedtablet contain: Cinnarizine (AsSustained Release) Excipients Approved colour used IP 75 mg q.s.
175 Cinnarizine and Dimenhydrinate Tablets Each uncoated Tablet contains: Cinnarizine Dimenhydrinate Excipients Approved Colour used IP BP 20mg 40mg q.s
176 Cinnarizine Tablet IP Each uncoated tablet contain: Cinnarizine Excipients Approved colour used IP 25 mg q.s.
177 Cinnarizine Tablets IP Each uncoated Tablet contains Cinnarizine Excipients Approved Coloured used IP 75mg q.s
178 Cinnarizineand Domperidone Tablets Each uncoatedTabletsContains: Cinnarizine Domperidone Excipients Approved colour used IP IP 20 mg 15 mg q.s.
179 Ciprofloxacin and Tinidazole Tablets Each film coated Tablet contains: Ciprofloxacin Hydrochloride Equ. to Ciprofloxacin Tinidazole Excipients Approved colour used IP IP 250mg 300mg q.s
180 Ciprofloxacin HCl, Fluocinolone Acetonide , Clotrimazole & Chlorocresol Cream Composition : Ciprofloxacin Hydrochloride Equ. to Ciprofloxacin Fluocinolone Acetonide Clotrimazole Chlorocresol ( as preservative) Cream Base IP IP IP IP 0.5%w/w 0.01%w/w 1.0% w/w 0.1%w/w q.s.
181 Ciprofloxacin Tablets IP Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin Excipients Colour:-Approved colour used IP 250 mg q.s.
182 Ciprofloxacin Tablets IP Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin Excipients Colour:-Approved colour used IP 500 mg q.s.
183 Ciprofloxacin, Metronidazole, Terbinafine Hydrochloride & Clobetasol PropionateCream Composition : Ciprofloxacin Hydrochloride equ. to Ciprofloxacin Metronidazole Benzoate equ. to Metronidazole Terbinafine Hydrochloride Clobetasol Propionate Preservatives : Methyl Paraben Propyl Paraben Cream Base IP IP IP IP IP IP 1.0%w/w 1.0%w/w 1.0%w/w 0.05%w/w 0.16%w/w 0.033%w/w q.s
184 Citicoline & Piracetam Syrup Each 5ml contains: Citicoline sodium Equ. to Citicoline Piracetam Flavoured Syrupybase Approved colour used IP IP 500mg 400mg q.s
185 Citicoline & PiracetamTablets Each FilmcoatedTabletsContains: Piracetam Citicoline sodium Equivalent toCiticoline Excipients Approved colour used IP IP 800 mg 500 mg q.s.
186 CiticolineTablets Each FilmcoatedTabletsContains: Citicoline sodium Equivalent toCiticoline Excipients Approved colour used IP 500 mg q.s.
187 Clarithromycin Tablet IP Each film coatedtablet contain: Clarithromycin Excipients Approved colour used IP 500 mg q.s
188 Clarithromycin Tablet IP Each film coated tablet Contains:- Clarithromycin Excipients Colour :-Approved colour used IP 250mg q.s
189 Clindamycin & NicotinamideGel Composition: Clindamycin Phosphate Equivalent toClindamycin Nicotinamide Gel base IP IP 1.0% w/w 4.0% w/w q.s.
190 Clindamycin Hydrochloride Capsule IP Each hardgelatin capsule contain: Clindamycin Hydrochloride Equivalent to Clindamycin Excipients Approved colour used in emptyhard gelatin capsule IP 300 mg
191 Clindamycin Phosphate & AdapaleneGel Composition Clindamycin phosphate Equivalent to clindamycin Adapalene Gel base IP IP 1 % w/w 0.1%w/w q.s.
192 Clindamycin PhosphateGel Composition:- Clindamycin Phosphate Equivalent toClindamycin Benzoyl PeroxideAnhydrous Gel Base IP IP 1.00% w/w 2.50% w/w
193 Clobetasol Propionate , Miconazole Nitrate, Neomycin Sulphate Cream Composition : Clobetasol Propionate Miconazole Nitrate Neomycin Sulphate Equ.toNeomycin Base Chlorocresol (as preservative) Cream base IP IP IP IP 0.05%w/w 2%w/w 0.5%w/w 0.1%w/w q.s.
194 Clobetasol Propionate & Salicylic Acid Ointment Composition: Clobetasol Propionate Salicylic acid Excipients In Ointment Base IP IP 0.05%w/w 6.0%w/w q.s.
195 Clobetasol Propionate &Fusidic Acid Cream Composition: Clobetasol Propionate Fusidic Acid In a water Miscible Cream Base Preservatives: Butylated Hydroxytoluene Sorbic Acid IP IP IP IP 0.05%W/W 2.00%W/W 0.005%W/W 0.200%W/W
196 Clobetasol Propionate cream IP Composition: Clobetasol Propionate Cream Base IP 0.05%w/w q.s.
197 Clobetasol Propionate, Fusidic Acid,Clotrima zole Cream Composition: Clobetasol Propionate Fusidic Acid Clotrimazole USP IP IP 0.05%W/W 2%W/W 1%W/W
198 Clobetasol Propionate, Gentamicin, Tolnaftate, Iodochlorhydroxyq uinoline and Clotrimazole Cream Composition : Clobetasol Propionate Gentamicin Sulphate Equ. to Gentamicin Tolnaftate Iodochlorhydroxyquinoline Clotrimazole Preservative : Chlorocresol Cream base IP IP IP IP IP IP 0.05%w/w 0.10%w/w 1.0%w/w 1.0%w/w 1.0%w/w q.s.
199 Clobetasol Propionate, Neomycin Sulphate, Tolnaftate, Iodochlorhydroxyq uinoline and Ketoconazole Cream Composition Clobetasol Propionate Neomycin Sulphate Tolnaftate Iodochlorhydroxyquinoline Ketoconazole In a Non greasycream base IP IP IP IP IP 0.05% w/w 0.1% w/w 1.0% w/w 1.0% w/w 2.0% w/w q.s
200 Clobetasol Propionate, Ofloxacin, Itraconazole, Cream Composition : Ofloxacin Ornidazole Itraconazole Clobetasol Propionate Methylparaben(As preservative) Propylparaben ( As preservative) Cream Base IP IP USP IP IP IP IP 0.75%w/w 2.0%w/w 1.00%w/w 0.05%w/w 0.20%w/w 0.02%w/w q.s.
201 Clobetasol, Neomycin & Clotrimazole Cream Composition : Clobetasol Propionate Neomycin Sulphate Clotrimazole Preservatives: Chlorocresol Cream Base IP IP IP IP 0.05%w/w 0.5%w/w 1.0%w/w 0.1%w/w q.s.
202 Clomifene Tablets IP Each uncoated tablet contains: Clomifene Citrate Excipients Approved colour used. IP 50mg q.s.
203 Clomiphene Citrate Tablets IP Each Uncoated Tablet Contains: Clomiphene Citrate Excipients IP 50mg q.s.
204 Clomiphene Tablet IP Each uncoated Tablet Contains :- Clomiphene Citrate Excipients Colour :- Approved colour used IP 50mg q.s
205 Clonazepam Tablet IP Each uncoated Tablet contains: Clonazepam Excipients Approved colour used IP 0.25mg q.s
206 Clonazepam Tablet IP Each uncoated Tablet contains: Clonazepam Excipients Approved colour used IP 0.5mg q.s
207 Clopidogrel and Aspirin Capsules Each hard gelatin capsule contains: Clopidogrel Bisulphate Equ. toClopidogrel ( as Pellets) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells. IP IP 75mg 75mg
208 Clopidogrel Bisulphate Tablet Each film coated Tablet Contains: Clopidogrel Bisulphate Equ. toClopidogrel Excipients Colour : Approved Coloured Used IP 75mg q.s
209 Clotrimazole & Beclomethasone Dipropionate Cream Composition : Clotrimazole Beclomethasone Dipropionate Preservatives: Benzyl Alcohol Methyl Paraben Cream base IP IP IP IP 1.0%w/w 0.025%w/w 1.0%w/w 0.15%w/w q.s
210 Clotrimazole Cream IP 1%w/w Composition Clotrimazole Preservatives : Benzyl Alcohal Water Miscible Base IP IP 1%w/w 1%w/w q.s.
211 Clotrimazole DustingPowder Composition : Each 100gm contains Clotrimazole Excipients IP 1gm q.s
212 Combikit of Azithromycin Tablet IP, Fluconazole Tablet IP & Secnidazole Tablet IP Each Combikit Contain: A) Azithromycin Tablet IP(1Tablet) Each film coated tablet contain: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Approved colour used B) FluconazoleTablet IP (1Tablet) Each uncoated tablet contain: Fluconazole Approved colour used C) SecnidazoleTablet IP(2Tablet) Each film coated tablet contain: Secnidazole Approved colour used IP IP IP 1 gm 150 mg 1 gm
213 Cyclosporine Capsules IP Each Hard Gelatin Capsule Contains : Cyclosporine Excipients Approved colour used. EmptyCapsule Shells. IP 250mg q.s.
214 Cyproheptadine Hydrochloride & Tricholine Citrate Drops Each ml contains : Cyproheptadinehydrochloride Equ. toanhydrous Cyproheptadine Hydrochloride Tricholine Citrate In a Flavoured palatable Base Approved colour used IP 1.5mg 55mg q.s.
215 Cyproheptadine Hydrochloride & Tricholine Citrate Syrup Each 5ml Contains:- Cyproheptadine Hydrochloride Tricholine Citrate (65%) Sorbitol Solution (70%) In flavoured Syrupy base Approved colour used IP IP 2 mg 275 mg q.s.
216 Cyproheptadine Hydrochloride Tablet IP Each uncoated tablet contains : - Cyproheptadine Hydrochloride (as anhydrous) Excipients Colour : Approved Colour Used IP 4mg q.s
217 Cyproheptadine Tablet IP Each uncoated tablet contains: Cyproheptadine Hydrochloride (Anhydrous) Excipients Approved colour used IP 4 mg
218 Cyproheptadine, B- Complex & Zinc Syrup Each 5ml contains : Cyproheptadine Hydrochloride Vitamin B1 Vitamin B6 Vitamin B12 Niacinamide D-Panthenol ZincSulphate Equ.ToElemental Zinc In a Flavoured SyrupyBase Approved colour used. IP IP IP IP IP IP IP 2mg 1mg 1.5mg 1mcg 15mg 1.5mg 1.8mg q.s.
219 Dapagliflozin & Metformin HCl (ER) Tablets Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. To Dapagliflozin Metformin Hydrochloride (as Extended Release) Excipients Approved colour used IP 10mg 1000mg q.s.
220 Dapagliflozin 10mg & Metformin HCl (ER) 500mg Tablets Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. to Dapagliflozin Metformin Hydrochloride (as Extended Release) Excipients Approved colour used IP 10mg 500mg q.s.
221 Dapagliflozin Tablet Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin Excipients Approved colour used 10 mg q.s
222 Dapagliflozin Tablets Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin Excipients Approved colour used 5 mg q.s
223 Dapoxetine Tablets IP Each film coated tablet contains: Dapoxetine Hydrochloride Equ. to Dapoxetine Excipients Approved colour used IP 30 mg q.s
224 Dapoxetine Tablets IP Each film coated tablet contains: Dapoxetine Hydrochloride Equ. to Dapoxetine Excipients Approved colour used IP 60 mg q.s
225 Deflazacort Oral Suspension Each 5ml contain: Deflazacort In flavoured Syrupybase Approved colour used 6 mg q.s.
226 Deflazacort Tablets Each uncoated tablet contains: Deflazacort Excipients Colour:- Approved colour used IP 12 mg q.s.
227 Deflazacort Tablets Each Uncoated Tablet Contains: Deflazacort Excipients Approved Colour used 18mg q.s
228 DeflazacortTablet Each uncoated tablet contain: Deflazacort Excipients Approved colour used 30 mg q.s.
229 DeflazacortTablets Each uncoated tablet contains:- Deflazacort Excipients Colour:-Approved colour used IP 6 mg q.s.
230 Desloratadine Tablet Each film coated Tablet Contains:- Desloratadine Excipients Approved colour used BP 5 mg q.s.
231 Desloratadine, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup Each 5ml contains: Desloratadine Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured syrupybase. Approved colour used. BP IP IP IP 2.5mg 30mg 50mg 1mg q.s.
232 Dexamethasone Tablets IP Each uncoated tablet contains:- Dexamethasone Excipients Colour : Approved Coloured Used IP 0.5 mg q.s.
233 Dexketoprofen Tablet Each film coated Tablet Contains: Dexketoprofen trometamol Equ. to Dexketoprofen Excipients Colour : Approved Coloured Used 25mg q.s
234 Dexlansoprazole Modified Release Capsule Each Hard Gelatin Capsule Contains: Dexlansoprazole (as modified release pellets) Excipients Approved colour used. IP 30mg q.s.
235 Dexlansoprazole Modified Release Capsule Each Hard Gelatin Capsule Contains: Dexlansoprazole (as modified release pellets) Excipients Approved colour used. IP 60mg q.s.
236 Dexlansoprazole Modified Release Capsule Each Hard Gelatin Capsules Contains: Dexlansoprazole (as Modified Release Pellets) Approved colour used in Pellets & EmptyCapsule Shells. IP 60mg
237 Dexrabeprazole (Enteric Coated) & Domperidone (Sustained Release) Capsule Each hardgelatin capsule contains : Dexrabeprazole Sodium (as Enteric Coated Pellets) Domperidone (as Sustained Release Pellets) Excipients Approved colour used. IP 10mg 30mg q.s.
238 Dextromethorphan HBR, Ambroxol HCL, Chlorpheniramine Maleate, Phenylephrine HCL & Menthol Syrup Each 5 ml contains: Dextromethorphan Hydrobromide Ambroxol Hydrochloride Chlorpheniramine Maleate Phenylephrine Hydrochloride Menthol Flavoured syrupy base Approved colour used IP IP IP IP IP 10 mg 15 mg 4 mg 5 mg 1 mg q.s
239 Dextromethorphan HBR, Ambroxol HCL, Chlorpheniramine Maleate, Phenylephrine HCL & Menthol Syrup Each 5 ml contains: Dextromethorphan Hydrobromide Ambroxol Hydrochloride Chlorpheniramine Maleate Phenylephrine Hydrochloride Menthol Flavoured syrupy base Approved colour used IP IP IP IP IP 10 mg 15 mg 2 mg 5 mg 1.5 mg q.s
240 Dextromethorphan HBR, Bromhexine HCL & Phenylephrine HCL Syrup Each 5 ml Contains: Dextromethorphan Hydrobromide Bromhexine Hydrochloride Phenylephrine Hydrochloride In a flavoured syrupybase Approved colour base IP IP IP 5 mg 4 mg 5 mg q.s.
241 Dextromethorphan HBR, Chlorpheniramine Maleate, Phenylephrine HCL Tablets Each uncoated tablet Contains: Dextromethorphan Hydrobromide Chlorpheniramine Maleate Phenylephrine Hydrochloride Excipients Approved colour used IP IP IP 10 mg 2 mg 5 mg q.s.
242 Dextromethorphan HBR, Phenylephrine HCL & Chlorpheniramine Maleate Syrup Each 5ml Contains:- Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Chlorpheniramine Maleate In flavoured Syrupybase Approved colour used IP IP IP 10 mg 5 mg 2mg q.s.
243 Dextromethorphan Hydrobromide & Chlorpheniramine maleate Syrup Each 5 ml contains :- Dextromethorphan Hydrobromide Chlorpheniramine maleate In flavoured syrupyBase Approved Colour Used. IP IP 10mg 4mg q.s.
244 Dextromethorphan Hydrobromide & Chlorpheniramine maleate Syrup Each 5 ml contains :- Dextromethorphan Hydrobromide Chlorpheniramine maleate In flavoured syrupyBase Approved Colour Used. IP IP 10mg 2mg q.s.
245 Dextromethorphan Hydrobromide, Cetirizine Hydrochloride, Ammonium Chloride, Ambroxol Hydrochloride & Menthol Syrup Each 5ml contains : Dextromethorphan Hydrobromide Cetirizine Hydrochloride Ammonium Chloride Ambroxol Hydrochloride Menthol In a flavoured SyrupyBase Approved colour used. IP IP IP IP IP 10mg 2.5mg 100mg 30mg 1mg q.s.
246 Dextromethorphan Hydrobromide, Phenylephrine hydrochloride & Chlorpheniramine Maleate Tablets Each uncoated tablet contains : Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Chlorpheniramine Maleate Excipients Colour: Tartrazine IP IP IP 10mg 5mg 2mg q.s
247 Diacerein , Glucosamine & Methylsulfonylmet hane Tablets Each film coated tablets contains: Diacerein GlucosamineSulphate potassium chloride Eq.to glucosamine Methylsulfonylmethane Excipients Approved colour used IP USP USP 50mg 750mg 446mg 250mg
248 Diclofenac & TolperisoneTablets Each uncoated sustained releaseTablet contains: Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved colour used IP 450mg 100mg q.s.
249 Diclofenac Diethyl amine, methyl Salicylate, linseed Oil &Menthol Gel Composition:- Diclofenac Diethyl amine Equ. toDiclofenacSodium 1.0%w/w) Linseed Oil Methyl Salicylate Menthol Benzyl Alcohol Excipients IP BP IP IP IP 1.16%w/w 3.0%w/w 10.0%w/w 5.0%w/w 1.0%w/w q.s.
250 Diclofenac Diethylamine , Thiocolchicoside, Virgin Linseed Oil, Methyl Salicylate & Menthol Gel Composition : Diclofenac Diethylamine Equ. to Diclofenac Sodium Thiocolchicoside Virgin Linseed Oil Menthol Methyl Salicylate Preservative : Benzyl Alcohol Gel Base IP IP BP IP IP IP 1.16%w/w 1.00%w/w 0.125%w/w 3.0%w/w 5.0%w/w 10%w/w 1.0%w/w q.s.
251 Diclofenac Paracetamol & Chlorzoxazone Tablets Each uncoated tablet contains:- Paracetamol Diclofenac Potassium Chlorzoxazone Excipients Colour:-Approved colour used IP BP USP 325 mg 50 mg 250mg q.s.
252 Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets Each film coatedTablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used BP IP IP 50mg 325mg 10mg q.s.
253 Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets Each film coatedTablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used. BP IP IP 50mg 325mg 10mg q.s.
254 Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved Colour Used BP IP IP 50mg 325mg 15mg q.s.
255 Diclofenac Potassium & Metaxalone Tablets Each uncoated Tablet contains: Diclofenac Potassium Metaxalone Excipients Approved colour used BP 50mg 400mg q.s.
256 Diclofenac Potassium & Paracetamol Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Excipients Approved colour used BP IP 50mg 325mg q.s.
257 Diclofenac Potassium & Paracetamol Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Excipients Approved colour used BP IP 50mg 325mg q.s.
258 Diclofenac Potassium & Serratiopeptidase Tablets Each film coated tablet contains : Diclofenac Potassium Serratiopeptidase (as enteric coated 20,000 unit of activated enzymatic activity of Serratiopeptidase ) Excipients Approved colour used. BP IP 50mg 10mg q.s.
259 Diclofenac Potassium & Serratiopeptidase Tablets Each film coated Tablet contains: Diclofenac Potassium Serratiopeptidase (Eq. toenzyme activityof 30000units of enteric coated granules) Excipients Approved colour used BP IP 50mg 15mg q.s.
260 Diclofenac Potassium & Thiocolchicoside Tablets Each enteric coated tablet contains: Diclofenac Potassium Thiocolchiside Excipients Approved colour used. I.P. I.P. 50mg 4mg q.s.
261 Diclofenac Potassium Sustained Release Tablets Each film coated sustainedrelease tablet contains: Diclofenac Potassium Excipients Approved colour used BP 100 mg q.s.
262 Diclofenac Potassium Tablets IP Each Filmcoated Tablet contains: Diclofenac Potassium Excipients Approved colour used IP 25mg q.s.
263 Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Chlorzoxazone Excipients Approved colour used BP IP IP 50mg 325mg 500mg q.s.
264 Diclofenac potassium, Paracetamol & Chymotrypsin Tablets (Discontinue AFTER GETTING APPROVAL AS PER S.No.892 which is in enteric coated formulation). Each Film coated TabletsContains: Diclofenac potassium Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymatic activity (Supplied by a purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients Approved colour used BP IP 50 mg 325 mg 50000AU q.s.
265 Diclofenac Potassium, Paracetamol & Trypsin Chymotrypsin Tablets Each enteric coated tablet contains: Diclofenac Potassium Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymatic activity. Excipients Approved colour used. BP IP BP 50mg 325mg 50000AU q.s.
266 Diclofenac Sodium , Paracetamol & Chlorzoxazone Tablets Each uncoated tablet contains:- Paracetamol Diclofenac Sodium Chlorzoxazone Excipients Colour:-Approved colour used IP IP USP 325 mg 50 mg 250mg q.s.
267 Diclofenac Sodium & Paracetamol Tablets Each film coated tablets contains: Diclofenac Sodium (as Enteric coated) Paracetamol Excipients Approved colour used IP IP 50mg 325mg
268 Diclofenac Sodium & Paracetamol Tablets IP Each Uncoated Bilayered tablet contains : Diclofenac Sodium Paracetamol Excipients Approved colour used. IP IP 50mg 325mg q.s.
269 Diclofenac Sodium & Serratiopeptidase Tablets Each film coatedTablet Contains: Diclofenac Sodium Serratiopeptidase (Eq. toenzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used. IP IP 50mg 10mg q.s.
270 Diclofenac Sodium & Thiocolchicoside Capsules Each hard gelatin capsule contain: Diclofenac Sodium Thiocolchicoside Excipients Approved colour used in emptyhard gelatin capsule IP IP 50 mg 4 mg q.s.
271 Diclofenac Sodium SR Tablet IP Each film coated Sustained Release tablet Contains Diclofenac Sodium Excipients Colour :-Approved colour used IP 100mg q.s
272 Diclofenac Sodium Tablets IP Each Enteric Coated Tablet Contains: Diclofenac Sodium Excipients Approved Colour Used IP 50mg q.s
273 Diclofenac, Methyl Salicylate & Menthol Topical Gel Diclofenac Diethylamine Eq. to Diclofenac Sodium Methyl Salicylate Menthol Benzyl Alcohol (As Preservative) Gel Base IP IP IP IP IP 2.32% w/w 2% w/w 10% w/w 5% w/w 1% w/w q.s
274 Diclofenac, Paracetamol and Serratiopeptidase Tablets Each film coated tablet contains:- Diclofenac Sodium Paracetamol Serratiopeptidase (Eq.toEnzyme activity30000 Units of enteric coated granules) Excipients Colour:-Approved colour used IP IP IP 50 mg 325 mg 15 mg q.s.
275 Dicyclomine Hydrochloride & Activated Dimethicone Drops Each ml contains: Dicyclomine Hydrochloride Activated Dimethicone Flavoured syrupybase. Approved colour used. IP IP 10mg 40mg q.s.
276 Dicyclomine Hydrochloride & Simethicone Suspension Each 5ml contains: Dicyclomine Hydrochloride Simethicone Emulsion USP Eq. to Simethicone In a flavoured syrupy base Approved colour used. IP USP 10mg 40mg q.s.
277 Dicyclomine Hydrochloride& Paracetamol Tablets Each uncoated Tablet contains: Dicyclomine Hydrochloride Paracetamol Excipients Approved colour used IP IP 20mg 500mg q.s.
278 Dicyclomine Hydrochloride& Simethicone Oral Drops Each ml contains : Dicyclomine Hydrochloride Simethicone In a flavoured syrupybase Approved Coloured used IP IP 10mg 40mg q.s
279 Digestive Enzyme Drops. Each ml contains: Alpha amylase (1:800) Pepsin Dil oil Anise oil Carawayoil Flavored syrupy base ApprovedColour Used IP IP BP BP BP 20mg 10mg 2mg 2mg 2mg q.s
280 Digestive Enzyme syrup Each 5 ml Contains :- Alpha Amylase(1:1200) (Fungal digest derived from Asper gillous oryzaedigest not less than 60gm of cooked starch) Pepsin (1:3000) (Digest not lessthan 30gm of coagulated eggalbumen) In a Flavoured syrupybase. Approved Colour Used IP IP 50mg 10mg q.s.
281 Digoxin Tablets IP Each Uncoated Tablet Contains: Digoxin Excipients IP 0.25mg q.s.
282 Digoxin Tablets IP Each uncoated Tablet Contains: Digoxin Excipients Approved colour used IP 0.25mg q.s.
283 Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate &Menthol Syrup Each 5ml contains : Diphenhydramine HCl Ammonium Chloride Sodium Citrate Menthol Flavoured SyrupyBase Approved colour used. IP IP IP IP 14.08mg 138mg 57.03mg 1.14mg q.s.
284 Disodium Hydrogen Citrate Syrup Each 5 ml contains :- Disodium Hydrogen Citrate In flavoured syrupyBase Approved Colour Used. BP 1.37gm. q.s.
285 Disulfiram Tablets Each Uncoated Tablet Contains:- Disulfiram Excipients Colour :- Approved colour used IP 200mg q.s
286 Domperidone DispersibleTablets Each uncoated dispersible tablet contains: Domperidone Excipients Approved colour used IP 10mg q.s
287 Doxofylline ( Sustained Release) & Montelukast Tablets Each Filmcoated Bilayered Tablet Contains : Doxofylline (as Sustained Release) Montelukast Sodium Equ. to Montelukast Excipients Approved colour used IP IP 400mg 10mg q.s.
288 Doxofylline & Ambroxol Hydrochloride Tablets Each Film coated Tablet Contains : Doxofylline Ambroxol Hydrochloride Excipients Approved colour used IP IP 400mg 30mg q.s.
289 Doxofylline Modified Release Tablets Each uncoated Modified Release Tablet contains : Doxofylline Excipients IP 650mg q.s.
290 Doxofylline Tablets IP Each filmCoatedTablet Contains:- Doxofylline Excipients Colour :-Approved colour used IP 400mg q.s.
291 Doxofylline Tablets IP Each uncoated Tablet Contains :- Doxofylline Excipients IP 400mg q.s.
292 Doxofylline(SR) & Montelukast Sodium Tablets Each uncoated tablet contains: Doxofylline (As sustainedrelease) Montelukast Sodium Eq. to Montelukast Excipients Approved colour used IP IP 400 mg 10 mg q.s.
293 Doxycycline & Lactic Acid Bacillus Capsule Each hard gelatin capsule contains Doxycycline Lactic Acid Bacillus Excipients Approved colour used in emptycapsule shells. IP 100mg 5 Million q.s.
294 Doxycycline & Lactic Acid Bacillus Tablets Each Film coated Tablet Contains : Doxycycline Hyclate Equ. To DoxycyclineLactic Acid Bacillus Excipients Approved colour used IP 100mg 5 Billion Spores q.s.
295 Doxycycline & Lacticacid Bacillus Capsules Each hard gelatin capsules contains : Doxycycline Hydrochloride Equ. to Doxycycline Lactic acid Bacillus Excipients Approved Colour used in Emptycapsules Shells. IP 100mg 5Million q.s
296 Doxycycline Hyclate Capsule USP Each hard gelatin capsule contains: Doxycycline Hyclate Equ. to Doxycycline Excipients Approved colour used in emptycapsule shells USP 100mg q.s.
297 Doxycycline Hyclate Tablets Each film coated Tablet Contains: Doxycycline Hyclate Equ. to Doxycycline Excipients Approved colour used. IP 100mg q.s.
298 Doxylamine Succinate & Pyridoxine HCl Tablets Each enteric coated tablet contains : Doxylamine Succinate Pyridoxine Hydrochloride Excipients Approved colour used USP IP 10mg 10mg q.s
299 Doxylamine succinate, Pyridoxine hydrochloride & Folicacid Tablets Each enteric coated tablets contains: Doxylamine succinate Pyridoxinehydrochloride Folic acid Excipients Approved colour used USP IP IP 20 mg 20 mg 5 mg q.s.
300 Doxylamine succinate, Pyridoxine hydrochloride & FolicacidTablets Each entericcoatedtablets contains: Doxylamine succinate Pyridoxinehydrochloride Folic acid Excipients Approved colour used BP IP IP 10 mg 10 mg 2.5 mg q.s.
301 Dried Aluminium Hydroxide , Magnesium Hydroxide, Simethicone & Sorbitol Oral Suspension Each 5ml contains : Dried Aluminium Hydroxide Gel Magnesium Hydroxide Activated Simethicone Sorbitol Solution (Non Crystallizing 70%) In a flavoured non syrupy base. Approved colour used IP IP IP IP 250mg 250mg 50mg 1.25gm q.s.
302 Dried Aluminium Hydroxide Gel , Magnesium Hydroxide Gel, Oxetacaine & Activated Dimethicone oral Suspension Each 5ml contains : Dried Aluminium Hydroxide Gel Magnesium Hydroxide Gel Oxetacaine Activated Dimethicone In a Flavoured non syrupybase Approved colour used IP IP IP IP 300mg 250mg 10mg 50mg q.s.
303 Dried Aluminium Hydroxide Gel, Magnesium hydroxide, Oxetacaine and Simethicone Suspension Each 5ml contain: Dried Aluminium Hydroxidegel Magnesium hydroxide Oxetacaine Simethicone In a flavoured sorbitol base Approved colour used IP IP BP IP 600 mg 300mg 10 mg 25 mg q.s.
304 Dried Aluminium Hydroxide, Magnesium Aluminium Silicate Hydrate, Magnesium Hydroxide & Simethicone Chewable Tablets Each uncoated Chewable Tablet Contains: Dried Aluminium Hydroxide Magnesium Aluminium Silicate Hydrate Magnesium Hydroxide Simethicone Excipients Colour: Erythrosine & Ponceau 4R IP IP IP 300mg 50mg 25mg 25mg q.s
305 Drotaverine hydrochloride & Mefenamic Acid Tablets Each film coated tablets: Drotaverine hydrochloride Mefenamic Acid Excipients Approved colour used IP IP 80 mg 250 mg q.s.
306 Drotaverine Hydrochloride Tablet IP Each film coated tablet Contains:- Drotaverine Hydrochloride Excipients Colour :-Approved colour used IP 40mg q.s.
307 Drotaverine Hydrochloride Tablets IP Each Film coated Tablet contains Drotaverine Hydrochloride Excipients Colour : Approved Coloured used IP 80mg q.s
308 Drotaverine Hydrochloride Tablets IP Each uncoated Tablet contains Drotaverine Hydrochloride Excipients Approved Coloured used IP 80mg q.s
309 Duloxetine Gastro- resistant Tablets IP Each enteric coated Tablet contains : Duloxetine Hydrochloride Equ. to Duloxetine Excipients Approved Colour used. IP 20mg q.s.
310 EbastineTablet IP Each film coated tablet contains: Ebastine Excipients Approved colour used IP 10 mg q.s
311 EbastineTablet IP Each film coated tablet contains: Ebastine Excipients Approved colour used IP 20 mg q.s
312 Elemental Iron , Elemental zinc &folic Acid Capsules Each hardgelatin Capsule contains: Elemental Iron (In the form of Carbonyl Iron ) Zinc Sulphate Monohydrate Equ. to Elemental Zinc Folic Acid Excipients Colour: - Approved colour used in hard Gelatin Capsule & shells. IP IP 50mg 61.8mg 22.5mg 0.5mg
313 Empagliflozin & Linagliptin Tablets Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used . 10mg 5mg q.s.
314 Empagliflozin & Linagliptin Tablets Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used . 25mg 5mg q.s.
315 Enteric coated Esomeprazole 40mg & Itopride Hydrochloride Sustained Release 150mg Capsules Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate Eq.to Esomeprazole (AsEntericCoated Pellets) Itopride Hydrochloride (In Sustained ReleaseForm) Excipients Approved colour used. IP IP 40mg 150mg q.s.
316 Ergotamine Tartrate, Caffeine, Paracetamol & Prochlorperazine Maleate Tablets Each uncoated tablet contain: Ergotamine Tartrate Caffeine (Monohydrate) Paracetamol Prochlorperazine Maleate Excipients Approved colour used (Banned drug 12/08/2024) IP IP IP IP 1 mg 100 mg 250 mg 2.5 mg q.s
317 Erythromycin StearateTablet IP Each film coated Tablet Contains: Erythromycin Stearate Equ. toErythromycin Excipients Colour:- Approved colour used IP 250mg
318 Escitalopram Oxalate & Clonazepam Tablet IP Each film coated Tablet Contains:- Escitalopram Oxalate Equivalent toEscitalopram Clonazepam Excipient Approved colour used IP IP 10 mg 0.5 mg q.s.
319 Escitalopram Oxalate Tablet Each film coated Tablet Contains: Escitalopram oxalate Equ. toEscitalopram Excipients Colour : Approved Coloured Used IP 10mg q.s
320 Esomeprazole (Enteric Coated) & Domperidone Sustained Release Capsules Each hard gelatin capsule contains:- Esomeprazole Magnesium Trihydrate Equ. to Esomeprazole (Asa enteric coated Pellets) Domperidone (as a Sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells. IP IP 40mg 30mg q.s
321 Esomeprazole (Enteric-coated) & Levosulpiride(Susta ined-release) Capsules Each hard gelatin Capsule contains : Esomeprazole Magnesium Trihydrate Equ. to Esomeprazole (as enteric –coated pellets) Levosulpiride (as sustained –release pellets) Excipients Colour: Titanium Dioxide IP is used in pellets & approved colour(s) are used in Emptycapsules shells. IP 40mg 75mg q.s
322 Esomeprazole Gastro–resistant Tablet IP Each Enteric coated Tablet contains :- Esomeprazole magnesium Trihydrate Equ. to Esomeprazole Excipients Colour : Approved Coloured Used IP 40mg q.s.
323 Etizolam Tablets Each film coated tablet contains: Etizolam Excipients Approved colour used 0.25 mg q.s
324 Etizolam Tablets Each film coated tablet contains: Etizolam Excipients Approved colour used 0.5 mg q.s
325 Etodolac Extended Release Tablets USP Each Film Coated Extended Release Tablet contains : Etodolac Excipients Approved colour used IP 600mg q.s.
326 Etodolac Tablets IP Each Film Coated Tablet contains: Etodolac Excipients Approved colour used IP 400mg q.s.
327 Etodolac Tablets IP Each Film Coated Tablet contains: Etodolac Excipients Approved colour used IP 300mg q.s.
328 Etophylline & Theophylline Prolonged Release Tablet IP Each Film coated prolonged release Tablet contains Etophylline Theophylline Anhydrous Equ. to Theophyllinehydrate Excipients Colour : Approved Coloured Used IP IP 115mg 35mg q.s
329 Etoricoxib & Paracetamol Tablets Each film coated tablet Contains:- Etoricoxib Paracetamol Excipients Colour :-Approved colour used IP IP 60mg 325mg q.s
330 Etoricoxib & Thiocolchicoside Tablets Each film coated tablet Contains:- Etoricoxib Thiocolchicoside Excipients Colour :-Approved colour used IP IP 60mg 4mg q.s
331 Etoricoxib and Pregabalin (Prolonged Release) Tablets Each uncoated bilayered tablet contains: Etoricoxib Pregabalin (As prolonged release) Excipients Approved colour used. IP IP 60 mg 75 mg q.s.
332 Etoricoxib tablets IP Each film coated tablet contains:- Etoricoxib Excipients Colour:-Approved Colour Used IP 90 mg q.s.
333 Etoricoxib tablets IP Each film coated tablet contains:- Etoricoxib Excipients Colour:-Approved Colour Used IP 60 mg q.s.
334 Etoricoxib tablets IP Each film coated tablet contains:- Etoricoxib Excipients Colour:- Approved Colour Used IP 120 mg q.s.
335 Etoricoxib,Linse ed Oil,Methyl Salicylate & Menthol Gel Etoricoxib Linseed Oil Methyl Salicylate Menthol IP BP IP IP 1.0% W/W 3.0% W/W 10.0% W/W 5.0% W/W q.s.
336 Febuxostat Tablet Each film coated tablet contains: Febuxostat Excipients Approved colour used 120 mg q.s
337 FebuxostatTablets Each film coated tablet contains:- Febuxostat Excipients Colour:-Approved colour used 40 mg q.s.
338 FebuxostatTablets Each film coated tablet contains:- Febuxostat Excipients Colour:-Approved colour used 80 mg q.s.
339 Ferric Ammonium Citrate, Folic Acid, Vit. B12 & Zinc Syrup Each 15ml contains : Ferric Ammonium Citrate Equ. to Elemental Iron Cyanocobalamin Folic Acid ZincSulphate In a Flavoured SyrupyBase. Approved Colour Used IP IP IP IP 200mg 41mg 7.5mcg 0.5mg 7mg q.s.
340 Ferrous Ascorbate , Folic Acid & Zinc Tablet Each film coatedTablet Contains: Ferrous Ascorbate Equ. toElemental Iron Folic Acid Zinc SulphateMonohydrate Equ. to Elemental Zinc Excipients Approved Colour Used. IP IP 100mg 1.5mg 22.5mg q.s.
341 Ferrous Ascorbate , Folic Acid, Methylcobalamin & Zinc Sulphate Monohydrate Tablet Each FilmCoated Tablet Contains: Ferrous Ascorbate Equ. ToElemental IronFolic Acid Methylcobalamin Zinc Sulphate Monohydrate Equ. To Elemental Zinc Excipients Approved Colour Used IP IP IP IP 100mg 1.1mg 1.5mg 22.5mg q.s.
342 Ferrous Ascorbate (SR) and L-Methylfolate Tablets Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron (In sustained release form) Calcium L-5 Methyltetrahydrofolate Eq. to L-Methylfolate Excipients Approved colour used. Appropriate overages of L-Methylfolate added to compensate loss on storage. I.P. U.S.P q.s. 100mg 0.5mg
343 Ferrous Ascorbate & Folic Acid Suspension Each 5ml contains:- Ferrous Ascorbate eq. toElemental Iron Folic Acid Excipients In flavored syrupybase ApprovedColour Used IP 30mg 550mcg q.s.
344 Ferrous Ascorbate & Folic Acid Tablets Each film coated tablet contains:- Ferrous Ascorbate Eq.toElementalIron Folic Acid Excipients Colour:-Approved colour used IP 100 mg 1.5 mg q.s.
345 Ferrous Ascorbate, Folic Acid & Methylcobalamin Tablets Each film coated tablets contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Methylcobalamin Excipients Approved Colour used. Appropriate overages of vitamins added to compensate the loss on storage. I.P. I.P. 100mg 1.5mg 1500 mcg qs
346 Ferrous Ascorbate, Folic acid, Cyanocobalamin & Zinc Tablet Each film coatedtablet contain: Ferrous Ascorbate Equ. toElmental Iron Folic acid Zinc Sulphate Monohydrate Equ. to Elmental Zinc Cyanocobalamin Excipients Approved colour used IP IP IP 100 mg 1.5mg 22.5mg 15mcg q.s
347 Ferrous Ascorbate, Folic Acid, Methylcobalamin Suspension Each 5ml contains : Methylcobalamin Ferrous Ascorbate Equ. toElemental Iron Folic Acid In a flavoured syrupyBase Approved colour used. IP IP 500mcg 30mg 0.5mg q.s.
348 Ferrous Gluconate, Folic Acid, Vitamin B12, Dibasic Calcium Phosphate & Zinc Sulphate Capsules Each hard gelatin capsule contains: Ferrous Gluconate Eq. to Elemental Iron Folic Acid Vitamin B12 (As gelatin triturate 0.1%) Dibasic Calcium Phosphate (Dihydrate) Zinc Sulphate Excipients Appropriate overages of vitamins added. Approved colour used in hard gelatin capsule shell. I.P. I.P. I.P. I.P. I.P. 259mg 30mg 0.5mg 2.5 mcg 100mg 33mg q.s.
349 Fexofenadine & Montelukast ChewableTablets Each Uncoated Chewable Tablet Contains : Fexofenadine Hydrochloride Montelukast Sodium Equ. to Montelukast Excipients IP IP 120mg 10mg q.s.
350 Fexofenadine & MontelukastTablet Each uncoatedTablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Montelukast Sodium Equ. toMontelukast Excipients Colour : ApprovedColour Used IP IP 120mg 10mg q.s.
351 Fexofenadine Hydrochloride & Montelukast Tablets Each film coated tablet contains: Fexofenadine Hydrochloride Montelukast sodium Equ. to Montelukast Excipients Approved colour used. IP IP 120mg 10mg q.s.
352 Fexofenadine Hydrochloride Tablet IP Each uncoatedTablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Excipients Colour : ApprovedColour Used IP 120mg q.s
353 Fexofenadine Hydrochloride Tablets IP Each FilmcoatedTabletsContains: Fexofenadine Hydrochloride Excipients Approved colour used IP 180 mg q.s.
354 Fexofenadine Hydrochloride Tablets IP Each film coated tablet contains: Fexofenadine Hydrochloride Excipients Approved colour used. IP 120mg q.s
355 Flavoxate Tablet IP Each film coated tablet contains: Flavoxate Excipients Approved colour used IP 200 mg q.s
356 Fluconazole Tablet IP Each Uncoated Tablet Contains: - Fluconazole Excipients Colour : -ApprovedColour used IP 150mg q.s.
357 Fluconazole Tablets IP Each uncoated tablet Contains: Fluconazole Excipients Approved colour used IP 400mg q.s.
358 FluconazoleTablets IP Each uncoated tablets contains: Fluconazole Excipients Approved colour used IP 200 mg q.s.
359 Flunarizine Tablets Each Uncoated Tablet Contains: Flunarizine (as Flunarizine Dihydrochloride) Excipients Approved colour used BP 5mg q.s.
360 Flunarizine Tablets IP Each uncoated Tablet contains Flunarizine Hydrochloride Excipients Approved Coloured used BP 10mg q.s
361 Fluoride Medicated Oral Gel Composition : Sodium Monofluorophosphate In a Flavoured Gel base Approved Colour used USP 0.35%w/w q.s
362 Fluoxetine & Alprazolam Tablets Each uncoated tablet contains: Fluoxetine Hydrochloride Eq. to fluoxetine Alprazolam Excipients Approved colour used IP IP 20 mg 0.25 mg q.s
363 Fluoxetine Capsules IP Each hard gelatin Capsule contains : Fluoxetine Hydrochloride Equ. to fluoxetine Excipients Approved colour used IP 20mg
364 FluoxetineTablet IP Each film coated tablet Contains:- Fluoxetine Hydrochloride Equ. toFluoxetine Excipients Colour :-Approved colour used IP 20mg q.s.
365 Flupentixol Dihydrochloride & Melitracen Hydrochloride Tablets Each film coated tablet contains : Flupentixol Dihydrochloride Equ. to Flupentixol Melitracen Hydrochloride Equ. to Melitracen Excipients Approved colour used. BP 0.5mg 10mg q.s
366 Flupirtine Maleate Capsules Each hard gelatin capsules contains : Flupirtine Maleate Excipients Approved colour used in EmptyCapsule Shells 100mg q.s.
367 Fluticasone Propionate Cream I.P Each g contains Fluticasone PropionateExcipients IP 0.05% w/w q.s.
368 Folic Acid Tablets IP Each uncoated Tablet Contains: Folic Acid Excipients Approved Colour used IP 10mg q.s
369 Folic Acid Tablets IP Each uncoated Tablet Contains: Folic Acid Excipients Approved Colour used IP 5mg q.s
370 Folic Acid, Methylcobalamin, Pyridoxine Hydrochloride & Docosahexaenoic Acid Capsules Each hard gelatin capsule contains: Folic Acid Methylcobalamin Pyridoxine Hydrochloride Docosahexaenoic Acid Powder (10%w/w) Appropriate overages of vitamins are added to compensate the loss on storage. IP IP IP 5mg 1500mcg 1.5mg 200mg q.s.
371 Frusemide Tablets IP Each uncoated tablet contains: Frusemide Excipients Approved colour used. IP 40mg q.s.
372 Fungal Diastase & Pepsin Drops Each ml contains: Diastase (1: 1200) (Fungal Diastase derived from Aspergillus oryzae, digest not less than 40g cooked starch) Pepsin (1: 3000) (Digest not less than 15g of coagulated egg Albumin) Flavoured syrupybase Approved colour used IP IP 33.33mg 5mg q.s.
373 Fungal Diastase & Pepsin Syrup Each 15ml contains : Fungal Diastase(1:1200) Pepsin (1:3000) In a flavoured syrupyBase Approved colour used IP IP 50mg 10mg q.s.
374 Furosemide Tablets IP Each Uncoated Tablet Contains: Furosemide Excipients IP 40mg q.s.
375 Fusidic Acid & Beclomethasone Dipropionate Cream Composition : Fusidic Acid Beclomethasone Dipropionate Preservatives Chlorocresol In a water Miscible cream Base IP IP IP 2.00%w/w 0.025%w/w 0.12%w/w q.s
376 Fusidicacid Cream IP Composition: Fusidic Acid Cream Base IP 2%w/w q.s.
377 Gabapentin & Methylcobalamin Tablet Each film coated tablet contains; Gabapentin Methylcobalamine Excipients Approved colour used IP IP 300mg 500mcg q.s
378 Gabapentin & Methylcobalamin Tablets Each film coated Tablet Contains: Gabapentin Methylcobalamin Excipients Approved colour used. IP IP 100mg 500mcg q.s.
379 Gabapentin and Nortriptyline Tablets Each film coated Tablet contains: Gabapentin Nortriptyline Hydrochloride Equ. to Nortriptyline Excipients Approved colour used IP IP 300mg 10mg q.s
380 Gabapentin Tablet IP Each film coated tablet contains: Gabapentin Excipients Approved colour used IP 100 mg q.s
381 Gabapentin Tablet IP Each film coated tablet contains: Gabapentin Excipients Approved colour used IP 400 mg q.s
382 Gabapentin Tablet IP Each film coated tablet contains: Gabapentin Excipients Approved colour used IP 800 mg q.s
383 Gliclazide & Metformin Hydrochloride(SR) Tablets Each Uncoated Bilayered Tablet Contains: Gliclazide Metformin Hydrochloride (as Sustained Release) Excipients Colour : Approved Coloured used IP IP 80mg 500mg q.s.
384 Glimepiride & Metformin Hydrochloride (SR) Tablets Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride (as Sustained Release form) Excipients Approved colour used IP IP 3mg 500mg q.s.
385 Glimepiride & Metformin Hydrochloride (SR) Tablets Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride (as Sustained Release form) Excipients Approved colour used IP IP 4mg 1000mg q.s.
386 Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride ( as Sustained Release) Excipients Approved colour used. IP IP 3mg 1000mg q.s.
387 Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets IP Each uncoated Bilayered tablet contains: Glimepiride Metformin Hydrochloride (as sustained release) Excipients Approved colour used. IP IP 1mg 1000mg q.s.
388 Glimepiride, Metformin Hydrochloride (ER) & Voglibose Tablets Each uncoated Bilayered Tablet Contains : Glimepiride Metformin Hydrochloride (as Extended Release) Voglibose Excipients Approved colour used IP IP IP 1mg 500mg 0.3mg q.s.
389 GlimepirideTablet IP Each uncoated tablet contains: Glimepiride Excipients Approved colour used IP 1 mg q.s.
390 GlimepirideTablet IP Each uncoated tablet contains: Glimepiride Excipients Approved colour used IP 2 mg q.s.
391 Granisetron Syrup Each 5ml contains : Granisetron Hydrochloride Equ. to Granisetron In a Flavoured SyrupyBase. BP 1mg q.s
392 Griseofulvin Tablets IP Each Uncoated Tablet Contains: Griseofulvin Excipients IP 500mg q.s.
393 Griseofulvin Tablets IP Each uncoated Tablet Contains: Griseofulvin Excipients Approved Colour Used IP 250mg q.s
394 Haloperidol Tablet IP Each Uncoated Tablet Contains: Haloperidol Excipients IP 5mg q.s.
395 Hydoxychloroquine Tablets IP Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients IP 200 mg q.s.
396 Hydoxychloroquine Tablets IP Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients IP 400 mg q.s.
397 Hydrochlorothiazid e tablet IP Each film coated tablet contains:- Hydrochlorothiazide Excipients Colour : Approved Colour Used IP 25mg q.s
398 Hydrochlorothiazid e tablet IP Each film coated tablet contains:- Hydrochlorothiazide Excipients Colour : Approved Colour Used IP 50mg q.s
399 Hydroquinone, Tretinoin & Fluocinolone Acetonide Cream Each 1gcontain: Hydroquinone Tretinoin Fluocinolone Acetonide In a cream Base USP USP IP 20 mg 0.25 mg 0.1 mg q.s.
400 Hydroxyzine Hydrochloride Tablet Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients Colour :- Approved Colour Used IP 10mg q.s.
401 Hydroxyzine Hydrochloride Tablet Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients Colour :- Approved Colour Used IP 25mg q.s.
402 Hydroxyzine Hydrochloride Tablets IP Each Film Coated Tablet Contains: Hydroxyzine Hydrochloride Excipients Approved colour used. IP 25mg q.s
403 Hyoscine Butylbromide IP Each Film coated Tablet Contains : Hyoscine Butylbromide Excipients Approved colour used. IP 10mg q.s.
404 Ibuprofen & Paracetamol Suspension Each 5ml Contains Ibuprofen Paracetamol Flavoured Palatable base Colour : Sunset Yellow FCF IP IP 100mg 162.5mg q.s
405 Ibuprofen & Paracetamol Tablets Each uncoated Tablet Contains Ibuprofen Paracetamol Excipients Approved Colour Used IP IP 400mg 325mg q.s
406 Ibuprofen Tablets IP Each film coated Tablet contains: Ibuprofen Excipients Approved colour used IP 200mg
407 Ibuprofen Tablets IP Each film coated Tablet contains: Ibuprofen Excipients Approved colour used IP 400mg
408 Iron &FolicAcid Syrup Each 15ml Contains : Iron(III) Hydroxide Polymaltose Complex Equ. to Elemental Iron Folic Acid In a Flavoured SyrupyBase Approved colour used. IP 50mg 0.5mg q.s.
409 Isosorbide Dinitrate Tablets IP Each Uncoated Tablet Contains: Isosorbide Dinitrate Excipients Approved colour used IP 5mg q.s.
410 Isoxsuprine Tablets (Sustained Release) Each uncoated Sustained Release Tablet Contains Isoxsuprine Hydrochloride Excipients Approved colour used IP 40mg q.s
411 Itopride Hydrochloride Sustained Release Capsule Each Hard Gelatin Capsule Contains: Itopride Hydrochloride (as Sustained Release Pellets) Excipients Approved colour used in Emptycapsule Shells. 150mg q.s.
412 Itraconazole & TerbinafineCream Composition : Itraconazole Terbinafine Hydrochloride Preservative : Methyl Paraben Phenoxyethanol Cream base BP IP IP IP 1.0%w/w 1.0%w/w 0.16%w/w 0.05%w/w q.s.
413 Itraconazole Capsules Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells BP 100mg q.s
414 Itraconazole Capsules Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells. BP 200mg q.s
415 Itraconazole Capsules Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells. USP 100mg q.s
416 Itraconazole Capsules Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells. USP 200mg q.s
417 Itraconazole Capsules BP Each HPMC capsules Contains: Itraconazole (as Pellets) Excipients Approved colour used in Empty capsule Shells. (Itraconazole Finished Product and Raw Material in IP 2022) BP 200mg q.s.
418 Itraconazole Cream 1% w/w Composition Itraconazole Methyl Paraben Propyl Paraben In cream base BP IP IP BP IP IP1 % w/w 0.1% w/w 0.05% w/w q.s.
419 Itraconazole Gel Composition Itraconazole Methyl Paraben Propyl Paraben In Gel base BP IP IP 1 % w/w 0.1% w/w 0.05% w/w q.s.
420 Ivermactin Tablet IP Each uncoated tablet contains: Ivermactin Excipients Approved colour used IP 6 mg q.s
421 Ivermactin Tablet IP Each uncoated tablet contains: Ivermactin Excipients Approved colour used IP 12 mg q.s
422 Ivermectin & Albendazole Tablets Each uncoated tablet contains: Ivermactin Albendazole Excipients Approved colour used IP IP 12 mg 400mg q.s
423 Ketoconazole Anti- Dandruff Shampoo Composition: Ketoconazole Conditioner Shampoo Base IP 2.0%w/v q.s
424 Ketoconazole Cream Composition : Ketoconazole Preservatives: Methyl Paraben Phenoxyethanol Cream Base IP IP IP 2.0%w/w 0.1%w/w 0.05%w/w q.s
425 Ketoconazole Lotion Composition : Ketoconazole In a perfumed conditioner Lotion Base Approved Colour used IP 2.0%W/V q.s
426 Ketoconazole Tablet IP Each uncoated tablet contain: Ketoconazole Excipients Approved colour used IP 200 mg q.s
427 Ketoconazole Zinc Pyrithione Shampoo Composition : Ketoconazole Zinc Pyrithione (ZPTO) Conditioner Shampoo Base Colour: Erythrosine IP 2.0%w/v 1.0%w/v q.s
428 Ketrolac Tromethamine DispersibleTablets Each uncoated dispersible tablets contains: Ketrolac Tromethamine Excipients Approved colour used IP 10 mg q.s.
429 L- Carnitine , L- Tartrate, Folic Acid & Methylcobalamin Tablets Each film coated Tablet contains: L-Carnitine L-Tartrate Equ. to L-Carnitine Methylcobalamin Folic Acid Excipients Approved colour used IP IP 500mg 1500mcg 1.5mg q.s.
430 L- Lysine with Multivitamin & Multimineral Syrup Each 5ml contains : ZincSulphate Nicotinamide L-Lysine Hydrochloride D- Panthenol Thiamine Hydrochloride Riboflavin Sodium Phosphate Pyridoxine Hydrochloride Copper Sulphate Potassium Iodide Sodium Selenite Pentahydrate Equ. to Selenium Cyanocobalamin Vitamin “A”(as Palmitate ) Cholecalciferol Vitamin “E” Acetate PleasantlyFlavoured SyrupyBase. Approved colour used. IP IP USP IP IP IP IP BP IP IP IP IP IP 22.5mg 7.5mg 5mg 1.25mg 0.75mg 0.75mg 0.5mg 100mcg 50mcg 10mcg 0.5mcg 1250IU 100IU 2.5IU q.s.
431 L-Arginine & Proanthocynadine Granules Sachet Each 5 gm sachet contain: L-Arginine Proanthocynadine Excipients Approved colour used IP 3.0 gm 75 mg q.s.
432 L-Carnitine L- Tartrate, Methylcobalamin and Folic Acid Tablets Each FilmCoated Tablet Contains: L-Carnitine L-Tartrate Methylcobalamin FolicAcid Excipients Approved colour used. IP IP 500mg 1500mcg 1.5mg q.s.
433 L-Mehtylfolate, Methylcobalamin & Pyridoxal-5-Phosphate Tablets Each film coated tablet contains: Calcium L-5 Methyltetrahydrofolate Equivalent to L-Methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used Appropriate overages of vitamins added to compensate the possible loss on storage. U.S.P. I.P. 5 mg 1500 mcg 0.5 mg q.s.
434 L-methylfolate Calcium, Methylcobalamin, Pyridoxal-5-Phosphate Tablets Each film coated tablet contains:- L-methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used . IP 1mg 1500mcg 0.5mg q.s.
435 Labetalol Tablets IP Each film coated Tablet Contains: Labetalol Hydrochloride Excipients Approved colour used. IP 50mg q.s
436 Labetalol Tablets IP Each film coated Tablet Contains: Labetalol Hydrochloride Excipients Approved colour used. IP 100mg q.s
437 Lactulose Solution USP Each 15 ml contain: Lactulose In flavoured Syrupybase Approved colour used USP 10 gm. q.s.
438 LactuloseSolution USP Each 15ml contain: Lactulose In flavoured Syrupybase Approved colour used USP 10 mg q.s.
439 Lansoprazole orally Disintegrating Tablets Each uncoated tablet contains: Lansoprazole (as enteric coated pellets) Excipients Approved colour used IP 15 mg q.s.
440 Lansoprazole Orally Disintegrating Tablets 30mg Each uncoated orallyDisintegrating tablet contains: Lansoprazole (As enteric coated pellets) Excipients Approved colour used. IP 30mg q.s.
441 Leflunomide Tablet IP Each film coated Tablet Contains: Leflunomide Excipients Colour : Approved Coloured Used IP 20mg q.s
442 Leflunomide Tablet IP Each film coated Tablet Contains: Leflunomide Excipients Colour : Approved Coloured Used IP 10mg q.s
443 Letrozole Tablets USP Each film coated Tablet contains: Letrozole Excipients Approved colour used. USP 2.5mg q.s.
444 Levetiracetam Tablet IP Each film Coated Tablet Contains :- Levetiracetam Excipients Colour :- Approved colour used IP 250mg q.s
445 Levetiracetam Tablet IP Each film Coated Tablet Contains :- Levetiracetam Excipients Colour :- Approved colour used IP 500mg q.s
446 Levocarnitine Oral Solution U.S.P. Each 5ml contains: Levocarnitine In a flavoured syrupy base Approved colour used. I.P. 500mg
447 Levocetirizine & Montelukast Suspension Each 5ml Contains : Levocetirizine Hydrochloride Montelukast Sodium Equ. to Montelukast In a flavoured syrupybase. Approved colour used IP IP 2.5mg 4mg q.s.
448 Levocetirizine Dihydrochloride & Montelukast DispersibleTablets Each uncoated dispersible Tablet contains : Levocetirizine Dihydrochloride Montelukast sodium Equ. to Montelukast Excipients IP IP 2.5mg 4mg q.s
449 Levocetirizine Dihydrochloride & Montelukast Sodium Syrup Each 5ml Contains:- LevocetirizineDihydrochloride Montelukast Sodium Equivalent to Montelukast In flavoured Syrupybase Approved colour used IP IP 2.5 mg 4 mg q.s.
450 Levocetirizine Dihydrochloride Syrup Each 5 ml contains: LevocetirizineDihydrochloride In a flavoured syrupy base Approved colour base IP 2.5 mg q.s.
451 Levocetirizine Dihydrochloride Tablets IP Each Uncoated Tablet Contains:- Levocetirizine Dihydrochloride Excipients Colour :-Approved colour used IP 5mg q.s.
452 Levocetirizine Dihydrochloride Tablets IP Each film Coated Tablet Contains : Levocetirizine Dihydrochloride Excipients Approved colour used. IP 5mg q.s.
453 Levocetirizine Dihydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets Each uncoated Tablet contains : Levocetirizine Dihydrochloride Phenylephrine Hydrochloride Paracetamol Excipients (Banned drug 12/08/2024) (Banned drug 12/08/2024) IP IP IP 2.5mg 10mg 500mg q.s.
454 Levocetirizine Dihydrochloride& Ambroxol Hydrochloride Syrup Each 5ml Contains: LevocetirizineDihydrochloride Ambroxol Hydrochloride Flavoured Syrupy Base Colour : Tartrazine IP IP 2.5mg 30mg q.s
455 Levocetirizine HCl, Ambroxol HCl, Guaiphenesin & Menthol Syrup Each 5ml Contains : Levocetirizine Hydrochloride Ambroxol Hydrochloride Guaiphenesin Menthol In a Flavoured syrupyBase. Approved Colour Used IP IP IP IP 2.5mg 15mg 50mg 1mg q.s.
456 Levocetirizine Hydrochloride & Ambroxol Hydrochloride Syrup Each 5ml contains: Ambroxol Hydrochloride Levocetirizine Hydrochloride In a flavoured Syrupy Base Approved colour Used. IP IP 30mg 5mg q.s.
457 Levocetirizine Hydrochloride & Ambroxol Hydrochloride Tablet Each film coated Tablet contains: Levocetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used. IP IP 5mg 60mg q.s.
458 Levocetirizine Hydrochloride Tablets IP Each Film coated Tablet Contains : Levocetirizine Hydrochloride Excipients Approved colour Used. IP 10mg q.s.
459 Levocloperastine Fendizoate Oral Suspension Each 5ml Contains : Levocloperastine Fendizoate Equ. To Levocloperastine HClIn a Flavoured Syrupy Base Approved colour used 35.4mg 20mg q.s.
460 Levodopa & Carbidopa Tablets IP Each Uncoated Tablet Contains: Carbidopa Equ.ToCarbidopa AnhydrousLevodopa Excipients Approved colour used IP IP 25mg 250mg q.s.
461 Levodropropi zine Syrup Each 5ml contains: Levodropropizine In a flavoured sugar freebase Approved colour used IP 30mg q.s.
462 Levodropropizine & Chlorpheniramine maleate Syrup Each 5ml contains:- Levodropropizine Chlorpheniramine maleate In a flavoured syrupy base Approved colour used . IP IP 30mg 2mg q.s.
463 Levofloxacin & Ornidazole Oral Suspension Each 5ml Contains : Levofloxacin Hemihydrate Equ. to Levofloxacin Ornidazole In a flavoured SyrupyBase. Approved colour used IP IP 125mg 125mg q.s.
464 Levofloxacin & OrnidazoleTablets Each film coated tablets contains: Levofloxacin hemihydrate Equivanent to Levofloxacin anhydrous Ornidazole Excipients Approved colour used IP IP 250 mg 500 mg q.s.
465 Levofloxacin Oral Solution IP Each 5 ml contains: Levofloxacin Hemhydrate Eq.to Levofloxacin Excipients Approved colour used. IP 125mg q.s.
466 Levofloxacin Tablets IP Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:-Approved colour used IP 250 mg. q.s.
467 Levofloxacin Tablets IP Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:-Approved colour used IP 500 mg. q.s.
468 Levofloxacin Tablets IP Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:-Approved colour used IP 750 mg. q.s.
469 Levosalbutamol Syrup 1mg/5ml Each 5ml contains: Levosalbutamol Sulphate Equ. to Levosalbutamol In a Flavoured SyrupyBase Approved colour used. IP 1mg q.s.
470 Levosalbutamol Syrup 2mg/5ml Each 5ml contains: Levosalbutamol Sulphate Equ. To Levosalbutamol In a Flavoured SyrupyBase Approved colour used. IP 2mg q.s.
471 Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup Each 5ml Contains : Levosalbutamol Sulphate Equ. to Levosalbutamol Ambroxol Hydrochloride Guaiphenesin Flavoured SyrupyBase Colour: Tartrazine IP IP IP 0.5mg 15mg 50mg q.s
472 Levosulpiride Tablets Each Uncoated Tablet Contains: Levosulpiride Excipients 25mg q.s.
473 Levothyroxine sodium Tablets USP Each uncoated Tablet Contains: Levothyroxine Sodium Equ. to Anhydrous Levothyroxine Sodium Excipients USP 50mcg q.s.
474 LinezolidTablet IP Each film coated tablet contains:- Linezolid Excipients Colour:-Approved colour used IP 600 mg q.s.
475 Lipid Based Amphotericin B Gel 0.1% w/w Each g contains: Amphotericin B Base IP 1.0mg q.s.
476 Liquid Paraffin & Milk of Magnesia Suspension Each15 ml (tablespoonful 133pprox..)Contains: Liquid Paraffin Milk ofMagnesia flavoured syrupy base Approvedcolour used IP IP 3.75ml 11.25ml q.s.
477 Lithium Carbonate Prolonged – Release Tablets IP Each uncoated Prolonged-Release tablet contains: Lithium Carbonate Excipients Approved colour used. IP 450mg q.s.
478 Loperamide Hydrochloride Tablets IP Each uncoated tablet contains:- Loperamide Hydrochloride Excipients Colour : Approved Coloured Used IP 2 mg q.s.
479 Loratadine Tablet USP Each uncoated table contains:- Loratadine Excipients Approved colour used USP 10 mg q.s.
480 Lornoxicam & Paracetamol Tablets Each film coatedTablet Contains:- Lornoxicam Paracetamol Excipients Colour :-Approved colour used IP IP 4mg 325mg q.s.
481 Lornoxicam & Paracetamol Tablets Each film coatedTablet Contains:- Lornoxicam Paracetamol Excipients Colour :-Approved colour used IP IP 8mg 325mg q.s.
482 Losartan Potassium & Amlodipine Besilate Tablet IP Each film coated tablet contains: Losartan Potassium Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 50 mg 5 mg q.s.
483 Losartan Potassium & Hydrochlorothiazid e Tablet IP Each film coated tablet contains: Losartan Potassium Hydrochlorothiazide Excipients Approved colour used IP IP 50 mg 12.5 mg q.s.
484 Losartan Potassium Tablet IP Each film coated tablet contains: Losartan Potassium Excipients Approved colour used IP 50 mg
485 Losartan potassium Tablets IP Each film coated tablet contains: Losartan potassium Excipients Approved colour used. IP 25mg q.s
486 Luliconazole cream Composition:- Luliconazole Preservative Benzyl Alcohal Cream Base IP IP 1%w/w 1%w/w q.s.
487 Luliconazole Cream 1% w/w Composition : Luliconazole Preservative Benzyl Alcohol Cream base IP 1%w/w 1%w/w q.s.
488 Luliconazole Lotion Composition : Luliconazole Lotion Base 1.0%w/v q.s
489 Lycopene with Anti-oxidant , Multivitamin & Multimineral Syrup Each 10ml Contains:- Lycopene 6% Vitamin A Concentrate (oily form) ( as Palmitate) Ascorbic Acid (Vitamin C) Vitamin E acetate Selenium (Assodium Selenate) Zinc (As zinc Gluconate) Manganese(as Manganese Gluconate) Iodine (as Potassium Iodide ) Copper (as cupric Sulphate) Thiamine hydrochloride Riboflavin sodium phosphate Pyridoxinehydrochloride In a Flavoured syrupybase. Approved Colour Used IP IP IP USP USP IP USP IP IP IP 1000mcg 2500IU 50mg 10IU 35mcg 3mg 2mcg 100mcg 500mcg 2mg 3mg 1.5mg q.s
490 Lycopene with Vitamins & Minerals Syrup Each 10ml contains : Lycopene(10% ) Dispersion Niacinamide Pyridoxine Hydrochloride Cyanocobalamin Folic Acid Sodium Selenate Equ. toElemental Selenium Zinc Gluconate Equ. toElemental Zinc Potassium Iodide Equ. toavailable Iodine Cupric Sulfate Equ. to Elemental Copper In a Flavoured SyrupyBase. Approved Colour used. USP IP IP IP IP USP IP USP 2000mcg 25mg 1.5mg 1mcg 100mcg 35mcg 3mg 100mcg 500mcg q.s.
491 Magaldrate & Simethicone Oral Suspension IP Each 5ml contains : Magaldrate (as anhydrous) Simethicone In a Flavored Syrupybase Approved colour used. IP IP 400mg 60mg q.s
492 Magaldrate, Simethicone & Domperidone Oral Suspension Each 5ml contains: Magaldrate Simethicone Domperidone Sorbitol Solution (70%) (Non-Crystallizing) Approved colour used IP IP IP IP 480mg 20mg 10mg q.s.
493 Magaldrate, Simethicone & Oxetacaine Suspension Each 5ml contains: Magaldrate Simethicone Oxetacaine Excipients Approved colour used IP IP BP 480mg 20mg 10mg q.s.
494 Magaldrate, Simethicone & Oxetacaine Suspension. Each 5ml contains: Magaldrate Simethicone Oxetacaine Excipients Approved colour used. IP IP BP 540mg 50mg 10mg q.s.
495 Magaldrate& Simethicone Oral Suspension Each 5ml contains: Magaldrate Simethicone Sorbitol Solution (70%) (Non Crystallising) In a flavoured sugar freeBase. Approved Colour Used. IP IP 400mg 20mg q.s.
496 Mecobalamin Tablets Each film coated Tablet contains: Mecobalamin Excipients Approved colour used. IP 1500mcg q.s.
497 Mecobalamin, Alpha Lipoic Acid, Benfotiamine, Folic acid,Chromium Picolinate,Inositol, Pyridoxine HCL, Vitamin D3, & Calcium Carbonate Tablets Each film coated tablet contains: Mecobalamin Alpha Lipoic Acid Benfotiamine Folic acid Chromium Picolinate Inositol, Pyridoxine HCL Vitamin D3 Calcium Carbonate Excipients Approved colour used IP IP IP IP IP IP IP IP 1500 mcg 100 mg 150 mg 1.5 mg 200 mcg 100 mg 3 mg 1000 IU 500mg q.s.
498 Mecobalamin, Alpha LipoicAcid, Folic Acid & Pyridoxine Hydrochloride Capsules Each hard Gelatin capsule contains : Mecobalamin Alpha LipoicAcid Folic Acid Pyridoxine Hydrochloride Excipients Approved Colour Used IP USP IP IP 1500mcg 100mg 1.5mg 3mg q.s
499 Mefenamic Acid & Dicyclomine HCl Tablets Each uncoated Tablet contains: Mefenamic Acid Dicyclomine HCl Excipients IP IP 250mg 20mg q.s
500 Mefenamic Acid & Dicyclomine Tablets IP Each uncoated tablet contains:- Mefenamic Acid Dicyclomine Hydrochloride Excipients Colour:-Approved Colour used IP IP 250 mg 10 mg q.s.
501 Mefenamic Acid & Paracetamol Suspension Each 5mlContains:- Mefenamic Acid Paracetamol In flavoured Palatablebase Approved colour used IP IP 100 mg 250 mg q.s.
502 Mefenamic Acid & Paracetamol Tablet Each uncoated tablet contain: Mefenamic Acid Paracetamol Excipients Approved colour used IP IP 500 mg 325 mg q.s.
503 Mefenamic Acid & Paracetamol Tablets Each uncoated tablet contains: Mefenamic Acid Paracetamol Excipients Approved Colour used IP IP 250mg 325mg q.s.
504 Mefenamic Acid Oral Suspension Each 5ml contains: Mefenamic Acid In a Flavoured SyrupyBase Approved colour used IP 100mg q.s.
505 Memantine Hydrochloride & Donepezil Hydrochloride Tablets Each film coated tablet contains: Memantine Hydrochloride Donepezil Hydrochloride Excipients Approved colour used. IP IP 5mg 5mg q.s.
506 Mesalamine Prolonged-release Tablets IP Each enteric coated Prolonged-release tablet contains:- Mesalamine Excipients Approved colour used . IP 1200mg q.s.
507 Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP Each uncoated bilayer tablet contains:- Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Colour:- Approved Colour Used IP IP 500 mg 1 mg q.s.
508 Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP Each uncoated bilayer tablet contains:- Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Colour:- Approved Colour Used IP IP 500 mg 2 mg q.s.
509 Metformin Hydrochloride (SR) & Glimepiride Tablets IP Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (as Sustained Release) Excipients Approved colour used. IP IP 2mg 500mg q.s.
510 Metformin Hydrochloride (Sustained Release) , Gliclazide (Sustained Release) & Pioglitazone Tablets Each uncoated Bilayered Tablet Contains: Metformin Hydrochloride (as Sustained Release) Gliclazide (as Sustained Release) Pioglitazone Hydrochloride Equ. to Pioglitazone Excipients Approved colour used. IP IP IP 500mg 30mg 15mg q.s.
511 Metformin Hydrochloride (Sustained Release) & Glimepiride Tablets IP Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (as Sustained Release) Excipients Approved colour used. IP IP 1mg 500mg q.s.
512 Metformin Hydrochloride & GliclazideTablets Each uncoated tablets contains: Metformin hydrochloride Gliclazide Excipients Approved colour used IP IP 500 mg 80 mg
513 Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP Each uncoated Bilayered tablet contains : Metformin Hydrochloride (as Prolonged Release) Glimepiride Excipients Approved colour used IP IP 1000mg 2mg q.s
514 Metformin Hydrochloride Sustained-Release Tablets Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients IP 500mg q.s.
515 Metformin Hydrochloride Sustained-Release Tablets Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients IP 850mg q.s.
516 Metformin Hydrochloride Sustained-Release Tablets Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients IP 1000mg q.s.
517 Metformin Hydrochloride Tablets IP Each uncoated sustainedrelease tablet contains: Metformin Hydrochloride Excipients Approved colour used IP 500 mg q.s.
518 Metformin hydrochloride,(ER) Pioglitazone and GlimepirideTablets Each uncoated Bilayered tablets contain: Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride Eq.to Pioglitazone Glimepiride Excipients Approved colour used IP IP IP 500 mg 15 mg 2 mg q.s
519 Metformin hydrochloride,(ER) Pioglitazone and Glimipride Tablets Each uncoated Bilayered tablets contain: Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride. Eq.to Pioglitazone Glimepiride Excipients Approved colour used IP IP IP 500 mg 15 mg 1 mg q.s
520 Methotrexate Tablets IP Each uncoated tablet contains: Methotrexate Excipients Approved colour used. IP 2.5mg q.s.
521 Methylcobalamin Sublingual Tablets Each uncoated sublingual tablet contains : Methylcobalamin Excipients IP 1500mcg q.s.
522 Methylcobalamin Tablets Each film coated Tablet Contains: Methylcobalamin Excipients Approved colour used. 1500mcg q.s.
523 Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules Each hard gelatin Capsules contains: Methylcobalamin Alpha LipoicAcid Inositol Folic Acid Chromium Polynicotinate Selenium Dioxide Benfotiamine Excipients Approved colour Used IP USP BP IP 1500mcg 100mg 100mg 1.5mg 200mcg 55mcg 150mg q.s
524 Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride,Thia mine Mononitrate & Folic Acid Tablets Each film coated tablet contains: Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used IP USP IP IP IP 1500mcg 100mg 3mg 10mg 1.5mg q.s.
525 Methylcobalamin, Calcium Citrate, Calcitriol, Folic Acid & Pyridoxine Hydrochloride Tablets Each film coated Tablet Contains: Methylcobalamin Calcium Citrate Calcitriol Folic Acid Pyridoxine Hydrochloride Excipients Approved colour used IP USP IP IP IP 1500mcg 750mg 0.25mcg 1.5mg 3mg q.s.
526 Methylcobalamin, L-Methylfolate & Pyridoxine HCl Tablets Each film coated Tablet Contains : Methylcobalamin L-Methylfolate Pyridoxine HCl Excipients Approved Colour Used IP IP 1500mcg 1MG 0.5mg q.s
527 Methylcobalamin, L-Methylfolate, Pyridoxal-Phosphate, Vitamin D3 & Docosahexaenoic Acid (DHA) Tablets Each film coated tablet contains: Methylcobalamin L-Methylfolate Pyridoxal Phosphate Vitamin D3 Docosahexaenoic Acid (DHA) Excipients Approved colour used. Appropriate overages of vitamins added to compensate the loss on storage. I.P. I.P. I.P. I.P. 1500 mcg 1.0 mg 0.5 mg 1000 IU 100 mg q.s.
528 Methylcobalamine, Alpha Lipoic Acid Vitamin D3,Pyridoxine Hydrochloride ,FolicAcid Tablets Each film coatedTablet Contains: Methylcobalamine Alpha LipoicAcid Vitamin D3 Pyridoxine Hydrochloride Folic Acid Excipients Approved Colour Used. IP USP IP IP IP 1500mcg 100mg 1000IU 3mg 1.5mg q.s.
529 Methylcobalamine, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Thiamine & Folic Acid Capsules Each hard gelatin capsule contains:- Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used in emptycapsule shells. IP USP IP IP IP 1500 mcg. 100 mg. 3 mg. 10 mg. 1.5 mg. q.s.
530 Methylprednisolone Tablets Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 8 mg q.s.
531 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 4 mg q.s.
532 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 2 mg q.s.
533 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 16 mg q.s.
534 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 16 mg q.s.
535 Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets Each uncoated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients Approved colour used IP IP 47.5 mg 50 mg 12.5 mg q.s.
536 Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets Each uncoated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients Approved colour used IP IP 23.75 mg 25 mg 12.5 mg q.s.
537 Metoprolol Succinate (ER) Tablets IP Each film coated tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used IP 47.5 mg 50 mg q.s.
538 Metoprolol Succinate Prolonged release Tablets IP Each film coated ProlongedreleaseTablet Contains Metoprolol succinate Equ. toMetoprolol Tartrate Excipients Colour :-Approved colour used IP 23.75mg 25mg q.s
539 Metoprolol Succinate(ER) & Amlodipine Besilate Tablets Each film coated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 47.5 mg 50 mg 5 mg q.s.
540 Metoprolol Succinate(ER) & Amlodipine Besilate Tablets Each film coated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 23.75 mg 25 mg 5 mg q.s.
541 Metoprolol SuccinateExtended release Tablets IP Each film coated Extended release Tablet Contains Metoprolol succinate Equ. ToMetoprolol TartrateExcipients Colour:-Approved colour used IP 11.875mg 12.5mg q.s.
542 Metronidazole and Povidone –Iodine Ointment Composition : Metronidazole Povidone–Iodine (Available Iodine 1.0%w/w) Water Soluble Ointment Base IP IP 2.0%w/w 10.0%w/w q.s
543 Metronidazole Oral solution Each 5ml contains : Metronidazole Benzoate Equ. to Metronidazole In a flavoured Syrupy Base. Colour : Approved Coloured Used IP 250mg q.s
544 Metronidazole Tablet IP Each film coated Tablet Contains: Metronidazole Excipients Colour : Approved Coloured Used IP 200mg q.s
545 Metronidazole Tablet IP Each film coated Tablet Contains: Metronidazole Excipients Colour : Approved Coloured Used IP 400mg q.s
546 Miconazole Nitrate Topical Powder USP Composition : Miconazole Nitrate Talc IP IP 2%w/w q.s
547 Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension Each 5 ml contain: Milk of Magnesia Liquid Paraffin Sodium Picosulphate Excipients In a Flavoured Sorbitol base Approved colour used IP IP BP 3.75ml 1.25ml 3.33 mg q.s.
548 Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate Suspension Each 5ml contains: Liquid Paraffin Milk of Magnesia Sodium Picosulphate Flavoured Non SyrupyBase Approved colour used IP IP BP 1.25ml 3.75ml 3.33mg q.s.
549 Minocycline Hydrochloride Tablet Each film coated Tablet Contains Minocycline Hydrochloride Equ. to Minocycline Excipients Colour : Approved Coloured Used USP 100mg q.s
550 Minoxidil Tablets IP Each uncoated tablet Contains: Minoxidil Excipients Approved colour used IP 2.5mg q.s.
551 Minoxidil Tablets IP Each Uncoated Tablet Contains: Minoxidil Excipients IP 5mg q.s.
552 Minoxidil Topical solution USP Each ml contains: Minoxidil Excipients Approved colour used IP 20mg q.s
553 Mometasone & Fusidic Acid Cream Composition:- Mometasone furoate Fusidic Acid Cream Base IP IP 0.10%w/w 2.00%w/w q.s.
554 Mometasone Furoate & Terbinafine Hydrochloride Cream Mometasone Furoate Terbinafine Hydrochloride Cream Base IP IP 0.1% w/w 1% w/w q.s.
555 Mometasone Furoate& Salicylic Acid Lotion Composition : Mometasone Furoate Salicylic Acid In an Emollient Base Containing Hexylene Glycol Preservatives : Methylparaben Propylparaben IP IP IP IP 0.10%w/w 3.50%w/w 0.20%w/w 0.02%w/w
556 Mometasone FuroateCream IP Composition : Mometasone Furoate Cream Base IP 0.1% w/w q.s.
557 Mometasone FuroateOintment Each g contains Mometasone Furoate Excipients IP 0.1% w/w q.s.
558 Mometasone, Hydroquinone and Tretinoine Cream Composition Mometasone furoate Hydroquinone Tretinoine Excipients IP USP USP 0.1 % w/w 2 % w/w 0.025 %w/w q.s.
559 Montelukast & Doxophylline (SR) Tablets Each uncoated tablet contains:- Montelukast Sodium Equivalent to Montelukast Doxophylline (AsSustained Release) Excipients Colour:-Approved colour used IP IP 10 mg 400 mg q.s
560 Montelukast & Levocetirizine HCL Dispersible Tablets Each uncoated dispersible tablet contains: Montelukast sodium Eq.to Montelukast Levocetirizine HCL Excipients Approved colour used IP IP 4 mg 2.5 mg
561 Montelukast & Levocetirizine HCl Tablets Each uncoated Bilayered Tablet Contains : Montelukast Sodium Equ. to Montelukast Levocetirizine Hydrochloride Excipients Approved colour used. IP IP 10mg 5mg q.s.
562 Montelukast sodium & Bambuterol Hydrochloride Tablets Each film coated Tablet contains: Montelukast sodium Equ. to Montelukast Bambuterol Hydrochloride Excipients Approved colour used IP BP 10mg 10mg q.s.
563 Montelukast Sodium & Desloratadine Tablet Each film coated Tablet Contains:- Montelukast Sodium Equivalent toMontelukast Desloratadine Excipients Approved colour used IP BP 10 mg 5 mg q.s
564 Montelukast Sodium & Levocetirizine Dihydrochloride DispersibleTablets Each Uncoated DispersibleTablet Contains: Montelukast Sodium Equ. To Montelukast LevocetirizineDihydrochloride Excipients Colour : Approved Coloured used IP IP 5mg 2.5mg q.s.
565 Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP Each uncoated Tablet contains: Montelukast sodium Equ. to Montelukast LevocetirizineDihydrochloride Excipients Approved colour used. IP IP 10mg 5mg q.s
566 Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP Each UncoatedTablet Contains:- Montelukast Sodium eq. to Montelukast LevocetirizineDihydrochloride Excipients Approved colour used IP IP 4mg 2.5mg q.s.
567 Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP Each Uncoated Tablet Contains:- Montelukast Sodium eq. to Montelukast Levocetirizine Hydrochloride Excipients Approved colour used IP IP 4mg 2.5mg q.s.
568 Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP Each film coated Tablet Contains:- Montelukast Sodium eq. to Montelukast Levocetirizine Hydrochloride Excipients Approved colour used IP IP 10 mg 5mg q.s
569 Montelukast Sodium Chewable Tablets Each UncoatedChewableTablet Contains: Montelukast sodium Equ. To Montelukast Excipients IP 4mg q.s.
570 Montelukast Sodium Tablets IP Each Film coated Tablet Contains : Montelukast Sodium Equ. to Montelukast Excipients Approved colour used IP 10mg q.s.
571 Montelukast Sodium, Fexofenadine Hydrochloride and Sustained Release Acebrophylline Tablets Each film coated Tablet contains: Montelukast sodium Equ. to Montelukast Fexofenadine Hydrochloride Acebrophylline (As sustainedrelease form) Excipients Approved colour used IP IP 10mg 120mg 200mg q.s
572 Montelukast sodium, Levoceterizine dihydrochloride & Ambroxol hydrochloride Tablets Each filmcoated tablets contains: Montelukast sodium Equivalent to Montelukast Levoceterizine dihydrochloride Ambroxol hydrochloride (As sustainedrelease) Excipients Approved colour used IP IP IP 10 mg 5 mg 75 mg q.s.
573 Moxifloxacin Hydrochloride Tablets Each Film coated Tablet Contains: Moxifloxacin Hydrochloride Equ. To Moxifloxacin Excipients Approved colour used. IP 400mg q.s
574 Moxonidine Tablets Each film coated tablet contains: Moxonidine Excipients Approved colour used BP 0.2mg q.s.
575 Moxonidine Tablets Each film coated tablet contains: Moxonidine Excipients Approved colour used BP 0.3mg q.s.
576 Multivitamin , Multimineral with LycopeneCapsules Each hard gelatin capsule contains Lycopene 6% Lutien 8% Beta Carotene (10% Dispersion) Vitamin B6 Vitamin B12 Vitamin D3 Folic Acid Calcium Pantothenate Niacinamide Biotin Lysine Hydrochloride Ferrous Fumarate Dibasic Calcium Phosphate Zinc Sulphate Magnesium Hydroxide Copper Sulphate Manganese Sulphate Chromium Chloride Sodium Selenate Excipients Approved colour used in emptycapsule shells. USP USP USP IP IP IP IP IP IP USP USP IP IP IP IP USP USP USP 5mg 6mg 10mg 1mg 5mcg 200IU 500mcg 5mg 25mg 10mcg 50mg 45mg 75mg 10mg 10mg 500mcg 500mcg 200mcg 100mcg q.s
577 Multivitamin Multimineral & Antioxidant suspension Each 5ml contains: Cholecalciferol (as Stabilized) Pyridoxine HCL Niacinamide Cyanocobalamin Zinc (as Zinc Gluconate ) B-Carotene Dispersion 2.5% Manganese (as Manganese Chloride Tetrahydrate) Molybdenum (as Sodium Molybdate Dihydrate ) Selenium (as Sodium Selenate) Lysine Hydrochloride Iodine(as Potassium Iodide ) Biotin Chromiume (as Chromium Chloride Hexahydrate) Inositol Excipients In a flavoured syrupy base Approved colour used. IP IP IP IP USP USP BP BP IP USP USP USP 200IU 1mg 15mg 1mcg 3mg 38mg 0.8mg 8mcg 10mcg 30mg 50mcg 10mcg 10mcg 10mg q.s.
578 Multivitamin, Iron, folic acid & Lysine Drops Each ml contains: Vitamin A(as Palmitate) Vitamin D3 Ferric Ammonium citrate (eq.to Element iron) Vitamin B12 Folic acid Lysine Monohydrochloride Thiamine Hydrochloride Vitamin B2 Vitamin B6 D-Panthenol Niacinamide Flavoured syrupy base Approved Colour Used IP IP IP IP IP USP IP IP IP IP IP 5000IU 400IU 25mg 5mcg 0.2mg 100mg 1mg 1mg 1mg 3mg 10mg q.s
579 Mupirocin ointment IP Composition :- Mupirocin Topical Ointment Base IP 2.0%w/w q.s.
580 Naproxen & Domperidone Tablets Each Film coatedtablet contains: Naproxen Domperidone Excipients Approved colour used. IP IP 250 mg 10 mg q.s
581 Naproxen & Domperidone Tablets Each film coated tablet contains: Naproxen Domperidone Excipients Approved colour used IP IP 500mg 10mg q.s
582 Naproxen Sodium & Domperidone Tablet Each uncoated tablet contain: Naproxen Sodium Domperidone Excipients Approved colour used IP IP 250 mg 10 mg q.s
583 Naproxen Sustained Release Tablets IP Each uncoated sustained release tablet contains: Naproxen Excipients Approved colour used IP 750mg q.s.
584 Naproxen Tablet IP Each uncoated tablet contain: Naproxen Excipients Approved colour used IP 250 mg q.s
585 Naproxen Tablet IP Each uncoated tablet contain: Naproxen Excipients Approved colour used IP 500 mg q.s
586 Nebivolol & Hydrochlorothiazid e Tablets Each uncoated Tablets Contains: Nebivolol Hydrochloride Equ. to Nebivolol Hydrochlorothiazide Excipients Approved colour used. IP IP 5mg 12.5mg q.s.
587 Nebivolol Hydrochloride Tablets IP Each uncoated tablet contains: Nebivolol Hydrochloride Eq. to Nebivolol Excipients Approved colour used. IP 5mg q.s.
588 Neomycin and Polymyxin B Sulfate and Bacitracin Zinc Ointment USP Composition : Each gm Contains : Polymyxin B Sulfate Equ. to Polymyxin Bacitracin Zinc Equ. to Bacitracin Neomycin Sulphate Equ. to Neomycin Preservative: Benzyl Alcohol Ointment Base USP IP IP IP 5000 units 400units 3400units 0.1%w/w q.s
589 Neomycin, Miconazole Nitrate & Fluocinolone Acetonide Cream Composition : Miconazole Nitrate Neomycin Sulphate Equ. to Neomycin Fluocinolone Acetonide Preservatives: Chlorocresol Cream Base IP IP IP IP 2.0%w/w 0.5%w/w 0.01%w/w 0.1%w/w q.s
590 Nicorandil Tablets IP Each uncoated Tablets Contains: Nicorandil Excipients IP 5mg
591 Nicorandil Tablets IP Each uncoated Tablets Contains: Nicorandil Excipients IP 10mg
592 Nifedipine Prolonged Release Tablets BP Each Prolonged Release film coated tablet contains: Nifedipine Excipients Approved colour used. BP 30mg q.s.
593 Nimesulide & Paracetamol Tablets Each uncoated tablet contains: Nimesulide Paracetamol Excipients BP IP 20 mg q.s.
594 Nimesulide & Paracetamol Tablets Each uncoated Bilayered Tablet contains: Nimesulide Paracetamol Excipients Approved colour used. BP IP 100mg 325mg q.s.
595 Nimesulide Mouth Dissolving Tablets Each uncoated Mouth dissolving Tablet contains : Nimesulide Excipients Approved colour used. BP 100mg q.s.
596 Nimesulide Tablets Each uncoated tablet contains:- Nimesulide Excipients Colour:-Approved colour used BP 100 mg q.s
597 Nimesulide, Paracetamol & Chlorzoxazone Tablets Each film coated tablet contains: Nimesulide Paracetamol Chlorzoxazone Excipients Approved colour used BP IP USP 100mg 325mg 250mg q.s
598 Nimesulide, Paracetamol, Phenylephrine HCl & Caffeine Tablets Each uncoated Tablet Contains: Nimesulide Paracetamol Phenylephrine Hydrochloride Caffeine (anhydrous) Excipients BP IP IP IP 100mg 325mg 10mg 25mg q.s.
599 Nimesulide, Paracetamol, Serratiopeptidase Tablets Each film coated tablet contains : Nimesulide Paracetamol Serratiopeptidase ((Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved colour used. BP IP IP 100mg 325mg 15mg
600 Nimesulide, Phenylephrine HCL, Cetirizine Dihydrochloride & Caffeine Tablets Each uncoated tablet contains:- Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine (anhydrous) Excipients Colour:-Approved colour used BP IP IP IP 100 mg 10 mg 5 mg 30 mg q.s.
601 Nimesulide, Phenylephrine HCl& Levocetirizine HCl Tablets Each uncoated tablet contains: Nimesulide Phenylephrine HCl Levocetirizine HCl Excipients Approved Colour used BP IP IP 100mg 5mg 5mg q.s.
602 Nimesulide, Phenylephrine Hydrochloride, Cetirizine Dihydrochloride & Caffeine Tablets Each film Coated Tablet Contains : Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine ( Anhydrous) Excipients Approved colour Used. BP IP IP IP 100mg 10mg 5mg 30mg q.s.
603 Nimodipine Tablets Each Film coated Tablet Contains : Nimodipine Excipients Approved colour used. IP 30mg q.s.
604 Nitazoxanide for Oral Suspension Composition : Each 5ml of reconstituted suspension contains Nitazoxanide Excipients Approved Colour used 100mg q.s
605 Nitrofurantoin SR Tablet Each FilmCoated Sustained ReleaseTablet Contains Nitrofurantoin Excipients Colour :-Approved colour used BP 100mg q.s.
606 Nitroglycerine Controlled Release Tablet Each uncoated Tablet contains: Diluted Nitroglycerine Equ. to Nitroglycerin (as Controlled Release) Excipients Approved colour used IP 2.6mg q.s.
607 Norfloxacin & TinidazoleTablets Each film coated tablet contains:- Norfloxacin Tinidazole Excipients Colour:-Approved colour used IP IP 400 mg 600 mg q.s.
608 Norfloxacin Tablets IP Each film coated Tablet Contains: Norfloxacin Excipients Approved Colour Use IP 400mg q.s
609 Nortriptyline & Gabapentin Tablets Each Film coated Tablet Contains:- Nortriptyline Hydrochloride Equivalent to Nortriptyline Gabapentin Excipients Approved colour used IP IP 10 mg 400 mg q.s.
610 Nortriptyline & PregabalineTablets Each film coatedTablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabaline Excipients Approved colour used IP IP 10 mg 75 mg q.s.
611 Nortriptyline, Pregabalin (SR) & Methylcobalamin Tablets Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin (as Sustained Release) Methylcobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
612 Nortriptyline, Pregabalin & Mecobalamin Tablets Each film coatedTablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin Mecobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
613 Nortriptyline, Pregabalin & Methylcobalamin Tablets Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin Methylcobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
614 Ofloxacin & Lactic Acid Bacillus Tablets Each Film coated Tablet Contains : Ofloxacin Lactic Acid Bacillus Excipients Approved colour used. IP 200mg 60 Million Spores q.s.
615 Ofloxacin & Metronidazole Suspension Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. to Metronidazole In a Flavoured SyrupyBase Colour : Sunset Yellow FCF IP IP 50mg 100mg q.s
616 Ofloxacin & Metronidazole Suspension Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. to Metronidazole Flavoured Syrupy base Approved colour used. IP IP 50mg 120mg q.s
617 Ofloxacin & Metronidazole Suspension Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. To Metronidazole In a Flavoured Palatable Base Colour: - Approved colour used. IP IP 100mg 200mg q.s.
618 Ofloxacin & Ornidazole Tablet IP Each FilmCoatedTabletContains: Ofloxacin Ornidazole Excipients Approved colour used IP IP q.s. 200 mg 500 mg
619 Ofloxacin & TinidazoleTablets Each film coated tablet contains: Ofloxacin Tinidazole Excipients Approved colour used. IP IP 200mg 600mg q.s.
620 Ofloxacin Oral Suspension IP Each 5 ml contains: Ofloxacin Excipients Approved colour used IP 50 mg
621 Ofloxacin oral suspension IP Each 5ml ofsuspension contains Ofloxacin In a flavoured Syrupybase. Approved Colour Used. IP 100mg q.s.
622 Ofloxacin Tablet IP Each film coated tablet contains:- Ofloxacin Excipients Approved colour used IP 400 mg q.s.
623 Ofloxacin Tablets IP Each film coated tablet contains:- Ofloxacin Excipients Colour:-Approved colour used IP 200 mg q.s.
624 Ofloxacin, Flucinolone Acetonide, Clotrimazole & Chlorocresol Cream Composition : Ofloxacin Flucinolone Acetonide Clotrimazole Chlorocresol (as Preservative) Cream Base IP IP IP IP 0.5%w/w 0.01%w/w 1%w/w 0.1%w/w q.s.
625 Ofloxacin, Metronidazole Benzoate & Simethicone Suspension Each 5ml Contains:- Ofloxacin MetronidazoleBenzoate Equivalent toMetronidazole Simethicone In flavoured Syrupybase Approved colour used IP IP IP 50 mg 120mg 10 mg q.s.
626 Ofloxacin, Ornidazole, Itraconazole and Clobetasole PropionateCream Composition Ofloxacin Ornidazole Itraconazole Clobetasole Propionate Methyl Paraben (Preservative) Propyl Paraben (Preservative) In cream base IP IP USP IP IP IP 0.75 % w/w 2.0 % w/w 1 % w/w 0.05 % w/w 0.20% w/w 0.02% w/w q.s.
627 OlanzapineTablet IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 5mg q.s.
628 OlanzapineTablet IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 2.5mg q.s.
629 OlanzapineTablet IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 7.5 mg q.s.
630 OlanzapineTablets IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 10 mg q.s.
631 Olmesartan & AmlodipineTablets IP IP 20 mg 5 mg q.s
632 Olmesartan & Chlorthalidone Tablets Each film coated tablet contains: Olmesartan Medoxomil Chlorthalidone Excipients Approved colour used IP IP 20 mg 12.5 mg q.s
633 Olmesartan & Hydrochlorothiazid e Tablets Each film coated tablet contains: Olmesartan Medoxomil Hydrochlorothiazide Excipients Approved colour used IP IP 20 mg 12.5 mg q.s
634 Olmesartan & Metoprolol SuccinateTablets Each film coated Bilayered tablet contains: Olmesartan Medoxomil Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used IP IP 20 mg 47.5 mg 50 mg q.s
635 Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazid e Tablets Each film coated Tablet Contains: Olmesartan Medoxomil AmlodipineBesylate Equ. To Amlodipine Hydrochlorothiazide Excipients ApprovedColour used. IP IP IP 40mg 5mg 12.5mg q.s.
636 Olmesartan, Amlodipine & Hydrochlorothiazid e Tablets Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate Eq. to Amlodipine Hydrochlorothiazide Excipients Approved colour used IP IP IP 20 mg 5 mg 12.5 mg q.s
637 Olmesarton Medoxomil & Hydrochlorthiazide Tablet Each film coated tablet contains: Olmesarton Medoxomil Hydrochlorthiazide Excipients Approved colour used IP IP 40 mg 12.5 mg q.s.
638 Olmesarton Medoxomil Tablet IP Each film coated tablet contains: Olmesarton Medoxomil Excipients Approved colour used IP 20 mg q.s.
639 Olmesarton Medoxomil Tablet IP Each film coated tablet contains: Olmesarton Medoxomil Excipients Approved colour used IP 40 mg q.s.
640 Omeprazole (Delayed- Release) and Domperidone (Sustained-Release) Capsules Each capsule contains: Omeprazole (as enteric coated pellets) Domperidone (as sustained Release pellets) Colour : Titanium Dioxide Approved colour used in emptycapsule shel IP IP 20mg 30mg
641 Omeprazole (EntericCoated) & Domperidone Capsules IP Each hard gelatin capsule contains:- Omeprazole (As Enteric Coated Pellets) Domperidone Excipients Approved colour used in emptycapsule shells. IP IP 20 mg 10 mg q.s
642 Omeprazole Capsule IP Each hard gelatin capsule contains:- Omeprazole (As enteric coated pellets) Excipients Approved colour used in emptycapsule shells. IP 20mg. q.s.
643 Ondansetron Oral Solution IP Each 5 ml contains: Ondansetron Hydrochloride Equ.to ondansetron Flavoured syrupybase IP q.s 2 mg q.s.
644 Ondansetron Oral Solution IP Each 5 ml contains: Ondansetron Hydrochloride Equ. to Ondansetron Flavoured Syrupy Base IP 4mg q.s.
645 Ondansetron Orally Disintegrating TabletsTablet IP Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride Equ. toOndansetron Excipients Approved colour used. IP 4mg
646 Ondansetron Orally Disintegrating TabletsTablet IP Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride Equ. toOndansetron Excipients Approved colour used IP 8mg
647 Oral Rehydrat ion Salts IP Each Pack contains: Sodium Chloride Potassium Chloride Sodium Citrate Dextrose Anhydrous Excipients IP IP IP IP 0.52g 0.30g 0.58g 2.70g q.s.
648 Oral Rehydration Salt IP Composition: Each sachet(21.8gm) contains: Dextrose (Anhydrous) Potassium Chloride Sodium Chloride Sodium Citrate Excipients IP IP IP IP 13.5gm 1.5gm 2.6gm 2.9gm q.s
649 Orlistat Capsules USP Each Hard Gelatin Capsules Contains: Orlistat ( as Pellets) Excipients Approved colour used in EmptyCapsule Shells USP 120mg q.s.
650 Ornidazole , Diloxanide & Simethicone Tablets Each film coated tablet contains: Ornidazole Diloxanide furoate Simethicone Excipients Approved colour used. IP IP IP 250mg 375mg 25mg q.s.
651 Ornidazole Tablets Each Film coated Tablet Contains : Ornidazole Excipients Approved colour used. IP 500mg q.s.
652 Oxaceprol Capsules Each Hard Gelatin Capsules Contains: Oxaceprol Excipients Approved colour used in emptyCapsule Shells 200mg q.s.
653 Pancreatin, Simethicone & Activated Charcoal Tablets Each film coated Tablet Contains: Pancreatin Simethicone Activated Charcoal Excipients Approved colour used IP IP IP 175mg 50mg 50mg q.s.
654 Pantoprazole Gastro-resistant and Domperidone Prolonged –release Capsules IP Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Prolonged Release Pellets) Excipients Approved colour used in emptycapsule shells. IP IP 40 mg 30 mg q.s
655 Pantoprazole Gastro-resistant and Domperidone Prolonged –release Capsules IP Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells. IP IP 40 mg 30 mg q.s
656 Pantoprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains:- Pantoprazole Sodium Eq. to Pantoprazole Excipients Colour:-Approved colour used IP 40 mg q.s.
657 Pantoprazole Sodium (Enteric coated) & Domperidone (Sustained Release) Capsules IP Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells. IP IP 40 mg 30 mg q.s
658 Pantoprazole Sodium (Enteric Coated) &Itopride Hydrochloride (Sustained Release) Capsule Each Hard Gelatin Capsule contain: Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As enteric coated pellets) Itopride Hydrochloride (As sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells IP 40 mg 150 mg q.s.
659 Pantoprazole Sodium (Enteric Coated)& Levosulpiride (sustained Release) Capsules Each Hard Gelatin Capsule Contains Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As a EntericCoated Pellets) Levosulpiride (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells IP 40 mg 75 mg q.s.
660 Pantoprazole Sodium & Domperidone Tablets Each enteric coated tablet contains:- Pantoprazole Sodium Eq. to Pantoprazole Domperidone Excipients Colour:-Approved colour used IP IP 40 mg 10 mg q.s.
661 Pantoprazole Tablets IP Each enteric coated Tablet contains : Pantoprazole sodium sesquihydrate Equ. to Pantoprazole Excipients Approved colour used IP 20mg q.s.
662 Paracetamol , Phenylephrine HCl & Cetirizine HCl, Tablets Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride Excipients Approved colour used. (Banned Drug 12/08/2024) IP IP IP 325mg 5mg 5mg q.s.
663 Paracetamol , Phenylephrine Hydrochloride &Cetirizine Dihydrochloride suspension Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride In a flavoured base Approved colour used (Banned drug 12/08/2024) IP IP IP 250mg 2.5mg 2.5mg q.s
664 Paracetamol (DT) Tablets BP Each uncoated dispersible tablet contains: Paracetamol Excipients Approved colour used. IP 650 mg q.s.
665 Paracetamol & Diclofenac Tablets IP Each uncoated tablet contains:- Paracetamol Diclofenac Sodium Excipients Colour:-Approved colour used IP IP 325 mg 50 mg q.s.
666 Paracetamol & Dicyclomine Hydrochloride Tablets Each uncoated Tablet contains: Paracetamol Dicyclomine Hydrochloride Excipients IP IP 325mg 20mg q.s.
667 Paracetamol & Domperidone MaleateSuspension Each 5ml contains : Paracetamol Domperidone Maleate Flavoured Palatable Base Colour : Sunset Yellow FCF IP IP 125mg 5mg q.s
668 Paracetamol & Domperidone Suspension Each 5ml contains: Paracetamol Domperidone In a Flavoured syrupyBase Approved colour used IP IP 250mg 5mg q.s.
669 Paracetamol & Domperidone Tablets Each uncoatedtablet contains : Paracetamol Domperidone Excipients Approved colour used. IP IP 325mg 10mg q.s.
670 Paracetamol & Mefenamic Acid Suspension Each 5ml Contains Paracetamol Mefenamic Acid In flavoured Palatable base Approved colour used IP IP 125mg 50mg q.s.
671 Paracetamol & Phenylephrine & Chlorpheniramine maleate Suspension Each 5 ml contains :- Paracetamol Phenylephrine HCl Chlorpheniramine maleate In flavoured syrupyBase. Approved Colour Used. IP IP IP IP 250mg 5mg 2mg q.s.
672 Paracetamol and CaffeineTablets IP Each uncoated Tablet contains: Paracetamol Caffeine Excipients IP IP 650mg 50mg q.s.
673 Paracetamol and CaffeineTablets IP Each Film Coated Tablet contains: Paracetamol Caffeine Excipients Approved Colour used. IP IP 650mg 50mg q.s.
674 Paracetamol Bilayered Sustained Release Tablets Each uncoated Bilayered Sustained Release Tablet contains : Paracetamol (As Immediate Release) Paracetamol (As Sustained Release) Excipients Approved Colour used. IP IP 300mg 700mg q.s.
675 Paracetamol Oral Drops Each ml Contains: Paracetamol Flavoured Palatable base IP 100mg q.s
676 Paracetamol Paediatric Oral Suspension IP Each 5ml contains: Paracetamol In a Flavoured SyrupyBase. Approved colour used IP 240mg q.s.
677 Paracetamol Paediatric Oral Suspension IP Each 5ml contains: Paracetamol In a Flavoured SyrupyBase Approved colour used IP 120mg q.s.
678 Paracetamol Suspension IP Each 5ml Contains Paracetamol Excipients Approved colour used IP 125mg q.s.
679 Paracetamol Suspension IP Each 5ml Contains Paracetamol In flavoured Palatablebase Approved colour used IP 250mg q.s.
680 Paracetamol Tablets IP Each uncoated tablet contains:- Paracetamol Excipients Colour:-Approved colour used IP 650 mg q.s.
681 Paracetamol Tablets IP Each uncoated tablet contains:- Paracetamol Excipients Approved colour used IP 500 mg q.s.
682 Paracetamol, Cetirizine Dihydrochloride & Phenylephrine Hydrochloride Tablets Each uncoated Tablet contains: Paracetamol Cetirizine Hydrochloride Phenylephrine Hydrochloride Excipients Approved colour used (Banned drug 12/08/2024) IP IP IP 500mg 5mg 10mg q.s
683 Paracetamol, Chlorpheniramine Maleate & Phenylephrine HCl Drops Each ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride Flavoured Palatable Base Approved Colour Used IP IP IP 125mg 1mg 2.5mg
684 Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Suspension Each 5ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride Flavoured Palatable Base Approved Colour Used. IP IP IP 125mg 1mg 2.5mg
685 Paracetamol, Dextromethorph nHBr,Cetirizine HCL, ,Phenylephrine HCL, Sodium Citrate & Menthol Suspension Each 5ml Contains: Paracetamol Dextromethorphan HBr Cetirizine HCL Phenylephrine HCL Sodium Citrate Menthol Ina flavoured syrupy base Approved colour use IP IP IP IP IP IP 250mg 5mg 2.5mg 5mg 25mg 1mg q.s
686 Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets Each uncoated tablet contains: Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Excipients Approved colour used . IP IP IP 500mg 10mg 2mg q.s.
687 Paracetamol, Phenylephrine HCL, & Chlorpheniramine MaleateSuspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate In flavoured Palatablebase Approved colour used IP IP IP 125 mg 5 mg 1 mg q.s.
688 Paracetamol, Phenylephrine HCl, Cetirizine Tablet Each Uncoated Tablet Contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Excipients Approved Colour Used (Banned drug 12/08/2024) IP IP IP 325mg 10mg 5mg q.s
689 Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used IP IP IP IP IP 250 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
690 Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used IP IP IP IP IP 125 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
691 Paracetamol, Phenylephrine HCL,Caffeine , & Chlorpheniramine Maleate Tablets Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Chlorpheniramine Maleate Excipients Approved colour used IP IP IP IP 500 mg 12.5 mg 30mg 2 mg q.s
692 Paracetamol, Phenylephrine Hydrochloride , Guaiphenesin, Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets Each uncoated Tablet contains: Paracetamol Phenylephrine Hydrochloride Guaiphenesin Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used. IP IP IP IP IP 325mg 5mg 50mg 5mg 15mg q.s.
693 Paracetamol, Phenylephrine Hydrochloride & Cetirizine Dihydrochloride Suspension Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride In a flavoured Syrupy Base. Approved colour used. (Banned drug 12/08/2024) IP IP IP 125mg 5mg 2mg q.s.
694 Paracetamol, Phenylephrine Hydrochloride & Cetirizine Hydrochloride Suspension Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride In a flavoured SyrupyBase. Approved colour used. (Banned drug 12/08/2024) IP IP IP 125mg 2.5mg 2.5mg q.s.
695 Paracetamol, Phenylephrine hydrochloride & Cetirizine hydrochloride Tablets Each uncoated tablets contains: Paracetamol Phenylephrine hydrochloride Cetirizine hydrochloride Excipients Approved colour used (Banned drug 12/08/2024) IP IP IP 500 mg 5 mg 5 mg q.s.
696 Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine MaleateSuspension Each 5ml Contains: Paracetamol Phenylephrine Hydrochloride Chlorpheniramine Maleate In a Flavoured Syrupy Base Colour: Sunset Yellow FCF IP IP IP 125mg 2.5mg 1mg q.s
697 Paracetamol, Phenylephrine Hydrochloride & Levocetirizine Dihydrochloride Tablets Each Uncoated Tablet Contains: Paracetamol Phenylephrine Hydrochloride LevocetirizineDihydrochloride Excipients (Banned drug 12/08/2024) IP IP IP 325mg 5mg 5mg q.s.
698 Paracetamol, Phenylephrine Hydrochloride, Cetirizine Hydrochloride , Dextromethorphan Hydrobromide & Caffeine Tablets Each uncoatedtablet contains : Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Dextromethorphan Hydrobromide Caffeine (Anhydrous) Excipients Approved colour used. IP IP IP IP IP 500mg 10mg 5mg 10mg 30mg q.s.
699 Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate &Caffeine Tablets Each uncoated Tablet contains: Paracetamol Phenylephrine Hydrochloride Chlorpheniramine Maleate Caffeine (Anhydrous) Excipients Approved Colour Used. IP IP IP IP 325mg 5mg 2mg 15mg q.s.
700 Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride & Caffeine (Anhydrous) Tablets Each uncoated tablet contains:- Paracetamol Phenylephrine Hydrochloride Diphenhydramine Hydrochloride Caffeine (Anhydrous) Excipients Colour:-Approved colour used IP IP IP IP 500 mg 5 mg 25 mg 30 mg q.s.
701 Paracetamol, Phenylpherine Hydrochloride , Caffeine & Diphenhydra mine Hydrochloride Tablets Each uncoated tablet contains: Paracetamol Phenylpherine Hydrochloride Caffeine (Anhydrous) Diphenhydramine Hydrochloride Excipients Approved colour used. IP IP IP IP 325mg 5mg 30mg 25mg q.s.
702 Paracetamol& Dicyclomine Hydrochloride Suspension Each 5ml contains: Paracetamol Dicyclomine Hydrochloride Flavoured Palatable Base Colour: Sunset YellowFCF IP IP 125mg 5mg q.s
703 Paroxetine Hydrochloride Tablet Each film coated Tablet Contains : Paroxetinehydrochloride Hemihydrate Equ. to Paroxetine Excipients Approved Colour used IP 20mg q.s
704 Paroxetine Prolonged Release tablet Each enteric–coated Bilayered prolonged release Tablet contains : Paroxetine Hydrochloride (as Hemihydrate) Equ. to Paroxetine Excipients Approved colour used IP 12.5mg q.s
705 Paroxetine Prolonged- Release Tablets IP Each enteric coated prolonged-release tablet contains: Paroxetine Hydrochloride Hemihydrate Eq.to Paroxetine Excipients Approved colour used IP 12.5mg
706 Permethrin Lotion Composition : Permethrin Base 5.0%w/v q.s
707 Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup Each 5ml contains : Phenylephrine hydrochloride Chlorpheniramine Maleate Flavoured syrupybase. Approved colour used IP IP 5mg 2mg q.s
708 Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops IP Each ml contains : Phenylephrine Hydrochloride Chlorpheniramine Maleate In a flavoured syrupy Base. Approved colour used. IP IP 2.5mg 1mg q.s.
709 Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops IP Each ml contains : Phenylephrine Hydrochloride Chlorpheniramine Maleate In a flavoured syrupyBase. Approved colour used. IP IP 5mg 2mg q.s.
710 Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Cetirizine Hydrochloride, Ambroxol Hydrochloride, Guaiphenesin Tablets Each uncoated Tablet Contains : Phenylephrine Hydrochloride Dextromethorphan Hydrochloride Cetirizine Hydrochloride Ambroxol Hydrochloride Guaiphenesin Excipients Approved colour used. IP IP IP IP IP 15mg 10mg 5mg 30mg 100mg q.s.
711 Phenylephrine Hydrochloride, Paracetamol & Cetirizine Hydrochloride Syrup Each 5ml Contains : Phenylephrine Hydrochloride Paracetamol Cetirizine Hydrochloride Flavoured Syrupy Base Colour : Sunset Yellow FCF (Banned drug 12/08/2024) IP IP IP 5mg 125mg 5mg q.s.
712 Phenytoin Tablets IP Each film coated tablet contains:- Phenytoin Sodium Excipients Colour : Approved Coloured Used IP 100 mg q.s.
713 Piracetam & CiticolineTablet s Each film coatedtablet contain: Piracetam Citicoline Sodium Eq. to Citicoline Excipients Approved colour used IP IP 400 mg 500 mg q.s.
714 Piracetam Tablets Each film coated tablet contains: Piracetam Excipients Approved colour used IP 800 mg q.s.
715 Piracetam Tablets IP Each film coatedtablet contain: Piracetam Excipients Approved colour used IP 400 mg q.s.
716 Piroxicame DispersibleTablets Each uncoated dispersible tablet contains: Piroxicame Excipients Approved colour used IP 20 mg q.s.
717 Posaconazole oral Suspension Each ml contains: Posaconazole Excipients Approved Colour Used IP 40mg q.s
718 Potassium Citrate and Citric Acid Oral Solution USP Each 5ml contains : Potassium Citrate Citric Acid Monohydrate Flavoured Sorbitol Base. Approved Colour Used IP IP 1100mg 334mg q.s
719 Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Solution Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used IP USP IP 1100mg 375mg 20mg q.s.
720 Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Suspension Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used IP USP IP 1100mg 375mg 20mg q.s.
721 Potassium Nitrate & Sodium Monofluorophosph ate Toothpaste Composition : Potassium Nitrate Sodium Monofluorophosphate In a Pleasantly Flavoured Base Colour :Brilliant Blue FCF BP USP 5.0%w/w 0.7%w/w q.s
722 Povidone –Iodine & Ornidazole Ointment Composition : Povidone Iodine (0.5% w/w Available Iodine) Ornidazole In an Ointment base IP IP 5.0%w/w 1.0%w/w q.s
723 Povidone Iodine GermicideGargle Composition: Povidone Iodine (0.2%w/vAvailable Iodine) Absolute alcohol contain In amint Flavour aqueous base IP 2.0% w/v 8.38% v/v q.s.
724 Povidone Iodine ointment Composition :- Povidone Iodine Excipients IP 5%w/w q.s.
725 Povidone Iodine Solution IP Composition : Povidone Iodine (available Iodine0.5%w/v) Purified Water IP IP 5%w/v q.s
726 Povidone iodine, Metronidazole and Aloevera Ointment Composition Povidoneiodine (AvailableIodine0.5% w/w) Metronidazole Aloevera Water Soluble ointment base. (Banned drug 12/08/2024) IP IP IP 5 % w/w 1 % w/w 1.50%w/w q.s.
727 Povidone Iodine& Metronidazole, Sucralfate Ointment. Composition : Povidone Iodine (available Iodine 0.5%w/w) Metronidazole Sucralfate In a water soluble Ointment base. IP IP USP 5.0 %W/W 1.0% W/W 7.0% W/W q.s.
728 Prasugrel Hydrochloride Tablets Each Film coated Tablet Contains : Prasugrel Hydrochloride Equ. to Prasugrel Excipients Approved colour used. 5mg q.s.
729 Prasugrel Hydrochloride Tablets Each Film coated Tablet Contains : Prasugrel Hydrochloride Equ. to Prasugrel Excipients Approved colour used 10mg q.s.
730 Prazosin Tablets IP Each uncoated tablet contains: Prazosin Hydrochloride Eq.to Prazosin Excipients Approved colour used. IP 5mg q.s.
731 Pre & Probiotic With L-Glutamine Capsules Each hard gelatin capsule contains: Fructo oligosaccharide L- Glutamine Bifidobecterium Bifidum Bifidobecterium Longm Lactobaccilus acidophillus Streptococusthermophillus Excipients Approved colour used emptycapsule shells USP 200 MG 100 mg 150million 150 million 300 million 150 million q.s.
732 Pre & Probiotic With ZincSachet Each 1 gm sachet contain: Lactobacillus acidophilus Lactobacillus rhamnosus Lactobacillus casei Lactobacillus plantarum Lactobacillus bulgaricus Bifidobacterium Longum Bifidobacterium infantis Bifidobacterium breve Streptococcus Thermophillus Fructo oligosaccharide Zinc Sulphate Monohydrate Eq. to elemental zinc Saccharomyces boulardil Excipients Containspermitted synthetic flavours USP 350 million 200 million 150 million 150 million 150 million 150 million 150 million 150 million 200 million 100 mg 10mg 0.05 billion q.s.
733 Prebiotic & Probiotic Capsules Each Hard Gelatin Capsule Contains:- Fructooligosaccharides Saccharomyces Boulardii Bifidobacterium Bifidum Bifidobacterium Longum Lactobacillus Acidophillus Streptococcus Thermophillus Excipients Approved colour used in empty capsule shells. 200mg 250 million spores 150 million spores 150 million spores 300 million spores 150 million spores q.s.
734 Prednisolone Tablet IP Each uncoated Tablet contains: Prednisolone Excipients Colour : Approved Coloured Used IP 5mg q.s
735 Prednisolone Tablet IP Each uncoated Tablet contains: Prednisolone Excipients Colour : Approved Coloured Used IP 10mg q.s
736 Prednisolone Tablet IP Each uncoated Tablet contains Prednisolone Excipients Colour : Approved Coloured Used IP 20mg q.s
737 Pregabalin , Methylcobalamin, Alpha Lipoic Acid Pyridoxine with Folic Acid Capsules Each hard gelatin capsule contains Pregabalin Methylcobalamin Alpha LipoicAcid Pyridoxine Hydrochloride Folic Acid Excipients Approved colour used in emptycapsule shells. IP IP USP IP IP 75mg 750mcg 100mg 3mg 1.5mg q.s
738 Pregabalin (SR), Methylcobalamin & Nortriptyline Tablets Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin (as Sustained Release) Methylcobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
739 Pregabalin (Sustained Release) & Methylcobalamin Tablets Each film coated Bilayered Tablet Contains: Pregabalin ( As Sustained Release) Methylcobalamin Excipients Approved Colour Used. IP IP 75mg 1500mcg q.s.
740 Pregabalin & Methylcobalamin Capsules IP Each hard gelatin capsule contains:- Pregabalin Methylcobalamin Excipients Approved colour used in emptycapsule shells. IP IP 75 mg. 750 mcg. q.s.
741 Pregabalin Capsules IP Each Hard Gelatin Capsule contains: Pregabalin Excipients Approved colour used in EmptyHard Gelatin Capsule IP 300mg q.s
742 Pregabalin Capsules IP Each Hard Gelatin Capsule contains: Pregabalin Excipients Approved colour used in EmptyHard Gelatin Capsule IP 75mg q.s
743 Pregabalin Capsules IP Each Hard Gelatin Capsule contains: Pregabalin Excipients Approved colour used in EmptyHard Gelatin Capsule IP 150mg q.s
744 Pregabalin Sustained Release Tablet Each Uncoated Sustained Release Tablet Contains : Pregabalin Excipients Approved colour used IP 75mg q.s.
745 Pregabalin, Methylcobalamin, Alpha Lipoic Acid, Folic acid & Pyridoxine Tablets Each film coated Tablet contains : Pregabalin Methylcobalamin Alpha Lipoic Acid Folic Acid Pyridoxine hydrochloride Excipients Approved colour used IP IP USP IP IP 75mg 1500mcg 100mg 1.5mg 3mg q.s
746 Pregabalin, Methylcobalamin, Benfotiamine, Pyridoxine Hydrochloride & Folic Acid Capsules Each Hard Gelatin Capsule Contains : Pregabalin Methylcobalamin Benfotiamine Pyridoxine Hydrochloride Folic Acid Excipients Approved colour used in EmptyCapsule Shells IP IP IP IP 75mg 750mcg 7.5mg 1.5mg 0.75mg q.s.
747 Pregabalin( Sustained Release) & Methylcobalamin Tablets Each film coatedTablet Contains: Pregabalin ( AsSustained Release) Methylcobalamin Excipients Approved Colour Used. IP IP 75mg 1500mcg q.s.
748 Probiotic Capsules Each hard gelatin capsule contains: Streptococcus Faecalis Clostridium Butyricum Bacillus Mesentericus Lactic acid bacillus (Lactobacillus sporogenes) Excipients Approved colour used. 30 Million 2 Million 1 Million 50 Million q.s.
749 Prochlorperazine Maleate Mouth Dissolving Tablets Each uncoated Tablet contains: Prochlorperazine Maleate Excipients IP 5mg q.s.
750 PromethazineSyrup Each 5ml Contains : Promethazine Hydrochloride Excipients Colour : Approved Colour Used IP 5mg
751 Propranolol Hydrochloride (SR) & Flunarizine Tablets Each Uncoated Bilayered Tablet Contains: Propranolol Hydrochloride (as Sustained Release) Flunarizine Dihydrochloride Equ. To Flunarizine Excipients Approved colour used. IP BP 40mg 10mg q.s.
752 Propranolol Hydrochloride Tablets Each Uncoated Tablet Contains: Propranolol Hydrochloride Excipients IP 40mg q.s.
753 Protein Hydrolysate, Calcium, Phosphorus, Vitamin B6, Cyanocobalamin Vitamin D3, Niacinamide, Folic Acid, Zinc & Iron Each 30g contains: Protein hydrolysate 20% Calcium (as Dibasic Calcium Phosphate) Phosphorus (as Dibasic Calcium Phosphate) Vitamin B6 (Pyridoxine Hydrochloride) Vitamin B12 (Cyanocobalamin) Vitamin D3 Niacinamide Folic Acid Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Excipients IP IP IP IP IP IP IP 5 g 225 mg 174 mg 0.5 mg 1 mcg 100 IU 15 mg 300 mg 5 mg 7.5 mg q.s.
754 Prulifloxacin Tablets Each film coated Tablet Contains: Prulifloxacin Excipients Approved Colour used 600mg
755 Pyridoxine Hydrochloride Tablets IP Each uncoated Tablet Contains: Pyridoxine Hydrochloride Excipients IP 50mg q.s.
756 Rabeprazole & Domperidone Tablets Each entericcoatedtablets contains: Rabeprazole Sodium Domperidone Excipients Colour:-Approved colour used IP IP 20 mg 10 mg q.s
757 Rabeprazole Gastro- Resistant Tablets IP Each entericcoatedtablets contains: Rabeprazole Sodium Excipients Colour:-Approved colour used IP 20mg q.s
758 Rabeprazole sodium (Enteric coated) & Aceclofenac (Sustained Release) Capsule Each hardgelatin capsule contains:- Rabeprazole Sodium (Asa enteric coated Pellets) Aceclofenac (as a Sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells IP IP 20mg 200mg q.s
759 Rabeprazole Sodium (Enteric coated) & Domperidone (Sustained Release) Capsules Each hard gelatin capsule contains:- Rabeprazole Sodium (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells. IP IP 20 mg 30 mg q.s
760 Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules Each Hard Gelatin CapsuleContains Rabeprazole Sodium (As a EntericCoated Pellets) Domperidone (10mg Immediate Release Pellets) (20mg Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells IP IP 20mg 30mg q.s.
761 Rabeprazole sodium (Enteric coated) & Levosulpiride (Sustained release) capsule Each hard gelatin capsule contains:- Rabeprazole Sodium (AsEntericCoated Pellets) Levosulpiride (AsSustained ReleasePellets) Excipients Approved colour used in emptycapsule shells. IP IP 20 mg 75 mg q.s
762 Rabeprazole sodium (Enteric coated) And Itopride Hydrochloride (sustained Release) Capsules Each hard gelatin capsule contains:- Rabeprazole Sodium (Asa enteric coated Pellets) Itopride Hydrochloride (as a Sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells. IP IP 20 mg 150 mg q.s
763 Rabeprazole Sodium 40mg (EC)& Domperidone 10(IR)20mg(SR) Capsules Each hard Gelatin Capsules Contains: Rabeprazole Sodium (as enteric coated pellets) Domperidone (as immediaterelease pellets) Domperidone (as sustained Release pellets) Excipients Approved Colour Used in emptyCapsules Shells IP IP IP 40mg 10mg 20mg
764 Racecadotril Capsules IP Each Hard Gelatin Capsules Contains: Racecadotril Excipients Approved Colour used IP 100mg
765 Ramipril & Hydrochlorothiazid e Tablets IP Each uncoated Tablet Contains: Ramipril Hydrochlorthiazide Excipients Approved colour used IP IP 2.5mg 12.5mg q.s.
766 Ramipril & Hydrochlorothiazid e Tablets IP Each uncoated Tablet Contains: Ramipril Hydrochlorthiazide Excipients Approved colour used IP IP 5mg 12.5mg q.s.
767 Ramipril Tablets IP Each uncoated Tablet Contains: Ramipril Excipients Approved colour used IP 1.25 mg q.s.
768 Ramipril Tablets IP Each uncoated Tablet Contains: Ramipril Excipients Approved colour used IP 5mg q.s.
769 Ramipril Tablets IP Each Uncoated Tablet Contains: Ramipril Excipients IP 2.5mg q.s.
770 Ranitidine Hydrochloride Tablets Each film coated Tablet contains: Ranitidine Hydrochloride Equ. to Ranitidine Excipients Approved colour used IP 150mg q.
771 Ranitidine Hydrochloride Tablets Each film coated Tablet contains: Ranitidine Hydrochloride Equ. to Ranitidine Excipients Approved colour used. IP 300mg q.s
772 Ranitidine Oral Solution IP Each 5ml Contains : Ranitidine Hydrochloride Equ. to Ranitidine In a Flavoured SyrupyBase Approved colour used IP 75mg q.s.
773 Riboflavin , Folic Acid, Niacinamide & Lactic Acid Bacillus Tablets Each Uncoated Tablet contains: Riboflavin Folic acid Niacinamide Lacticacid bacillus Excipients Colour: Tartrazine IP IP IP 10mg 1.5mg 100mg 60Million Spores q.s
774 Riboflavin, Folic Acid, Niacinamide with Lactic Acid Bacillus Tablets Each uncoated Tablet Contains: Riboflavin Folic Acid Niacinamide Lactic Acid Bacillus Excipients Approved colour used. IP IP IP 10mg 1.5mg 50mg 120 Million spores q.s.
775 Rifaximin & Metronidazole Suspension Each 5 ml contains: Rifaximin Metronidazole Benzoate Eq. to Metronidazole In a flavoured base Excipients Approved colour used. I.P. I.P. 100mg 200mg q.s.
776 Rifaximin Oral Suspension Each 5ml contains: Rifaximin Excipients Approved Colour Used. 100mg q.s.
777 Rifaximin Tablets Each filmcoatedtablets contains: Rifaximin Excipients Approved colour used 550 mg q.s.
778 Rifaximin Tablets Each filmcoated tablets contains: Rifaximin Excipients Approved colour used 400 mg q.s.
779 RifaximineTablets Each filmcoated tablets contains: Rifaximine Excipients Approved colour used 200 mg q.s.
780 Rosuvastatin , Clopidogrel and Aspirin Capsule Each hard gelatin Capsule contains : Rosuvastatin Calcium Equ. to Rosuvastatin (as pellets) Clopidogrel Bisulphate Equ. to Clopidogrel (as pellets) Aspirin (as enteric coatedpellets) Excipients Approved colour used in emptycapsule shells. IP IP IP 20mg 75mg 75mg q.s.
781 Rosuvastatin , Clopidogrel and Aspirin Capsules Each Hard Gelatin Capsule Contains : Rosuvastatin Calcium Equ. to Rosuvastatin(as pellets) Clopidogrel Bisulphate Equ. to Clopidogrel ( as pellets) Aspirin (as Enteric Coated Pellets) Excipients Approved colour used in emptyCapsule Shells IP IP IP 10MG 75MG 75MG q.s
782 Rosuvastatin & Clopidogrel capsule Each hard gelatin capsule contains: Rosuvastatin calcium Equ. To Rosuvastatin (as pellets Form) Clopidogrel Bisulphate Equ. To Clopidogrel (as pellets Form) Excipients Approved colour used in emptycapsule shells. IP IP 10mg 75mg q.s.
783 Rosuvastatin & FenofibrateTablets Each film coated Tablet Contains: Rosuvastatin Calcium Equ. to Rosuvastatin Fenofibrate Excipients Approved colour used IP IP 20mg 160mg q.s.
784 Rosuvastatin & FinofibrateTablet IP Each film coated tablet contains:- Rosuvastatin calcium Equ. toRosuvastatin Finofibrate Excipients Colour : Approved Coloured Used IP IP 10mg 160mg q.s.
785 Rosuvastatin and Aspirin (EC) Capsules Each hard gelatin capsule contains: Rosuvastatin Calcium Equ. to Rosuvastatin (In IR Pellets form) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells. IP IP 10mg 75mg
786 Rosuvastatin and Aspirin (EC) Capsules Each hard gelatin capsule contains: Rosuvastatin Calcium Equ. to Rosuvastatin (In IR Pellets form) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells. IP IP 20mg 75mg
787 Rosuvastatin and Aspirin Capsules Each Hard Gelatin Capsule contain: Rosuvastatin calcium Equivalent to Rosuvastatin (As pellets) Aspirin (As enteric coated pellets) Excipients Approved colour used in emptycapsule shells IP IP 10 mg 75 mg
788 Rosuvastatin Tablet IP Each film coated tablet Contains : Rosuvastatin Calcium Equ. to Rosuvastatin Excipients Approved Colour Used IP 40mg
789 Rosuvastatin Tablets IP Each filmcoated tablet contain Rosuvastatin Calcium Eq.to Rosuvastatin Excipients Approved colour used IP 5 mg q.s.
790 Rosuvastatin Tablets IP Each filmcoated tablet contain Rosuvastatin calcium Eq.to Rosuvastatin Excipients Approved colour used IP 10 mg q.s.
791 Rosuvastatin Tablets IP Each filmcoated tablet contain Rosuvastatin Calcium Eq.to Rosuvastatin Excipients Approved colour used IP 20 mg q.s.
792 Roxithromycin & Ambroxol Tablets Each film coatedtablet contain: Roxithromycin Ambroxol Hydrochloride Excipients Approved colour used IP IP 150 mg 60 mg q.s
793 Roxithromycin Tablets Each filmcoated tablets contains: Roxithromycin Excipients Approved colour used IP 150 mg q.s.
794 Serratiopeptidase tablet IP Each film coated tablet Contains:- Serratiopeptidase (Equ. toEnzyme activity20,000Units of enteric coated granules) Excipients Colour : ApprovedColour Used IP 10mg q.s
795 Sertraline Hydrochloride Tablets IP Each film coated Tablet Contains: Sertraline Hydrochloride Equ. To Sertraline Excipients ApprovedColour used. IP 50mg q.s.
796 Sertraline Tablets IP Each film coated tablets contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved colour used. IP 25mg q.s.
797 Sevelamer Carbonate Tablets Each film coated Tablet Contains: Sevelamer Carbonate Excipients Approved colour used 400mg q.s.
798 Sildenafil Citrate Tablets IP Each film coated tablet contains:- Sildenafil Citrate Eq. tosildenafil Excipients Colour:- Approved Colour used IP 50 mg q.s
799 Sildenafil Citrate Tablets IP Each film coated tablet contains:- Sildenafil Citrate Eq. tosildenafil Excipients Colour:- Approved Colour used IP 100 mg q.s.
800 Silodosin Capsules Each hard gelatin capsules contain: Silodosin Excipients 8 mg q.s.
801 Silodosin Capsules Each hard gelatin capsules contain: Silodosin Excipients 4 mg q.s.
802 Silver Nitrate, Chlorhexidine Gluconate, Aloevera & Allantoin Cream Composition : Silver Nitrate Chlorhexidine Gluconate Solution Allantoin AloeVera extract Preservatives: Chlorocresol Cream Base IP IP IP IP 0.2%w/w 0.2%w/w 0.1%w/w 15.0%w/w 0.1%w/w q.s
803 Silver Sulphadiazine & Chlorhexidine GluconateCream Composition : Silver Sulphadiazine Chlorhexidine Gluconate solution Equ. to Chlorhexidine Cream base IP IP 0.5%w/w 0.2%w/w q.s.
804 Silymarin, L-Ornithine Laspartate, with B-Complex syrup Each 5ml contains : Silymarin (80%) L-Ornithine L- aspartate Sorbitol solution (70%) Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Niacinamide Calcium D-Pantothenate Flavoured Syrupy Base. Approved Colour Used IP IP IP IP IP IP IP 40mg 150mg 500mg 2.5mg 2.5mg 1.5mg 5mcg 25mg 5mg q.s
805 Simethicone , Dill Oil & Fennel Oil Drops Each ml contains: Simethicone Dill Oil Fennel Oil Flavoured palatable base. Approved colour used IP BP IP 40mg 0.005ml 0.0007ml q.s.
806 Simethicone, Norfloxacin & Metronidazole Suspension Each 5ml contains : Simethicone Norfloxacin Metronidazole Benzoate Equ. to Metronidazole In a flavoured SyrupyBase Approved colour used IP IP IP 10mg 125mg 125mg q.s.
807 Sitagliptin Phosphate & Metformin Hydrochloride Tablets Each film coated Tablet Contains : Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Metformin Hydrochloride Excipients Approved colour used. IP IP 64.25mg 50mg 850mg q.s.
808 Sitagliptin Phosphate & Metformin Hydrochloride Tablets Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Metformin Hydrochloride Excipients Approved colour used IP 64.25mg 50mg 500mg q.s.
809 Sitagliptin Phosphate & Metformin Hydrochloride Tablets Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Metformin Hydrochloride Excipients Approved colour used IP 64.25mg 50mg 1000mg q.s.
810 Sitagliptin PhosphateTablet Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used IP 25mg q.s
811 Sitagliptin PhosphateTablet Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used IP 50mg q.s
812 Sitagliptin PhosphateTablet Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used IP 100mg q.s
813 Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension Each 5 ml contains: Sodium Alginate Sodium Bicarbonate Calcium Carbonate In a flavoured base. Approved colour used IP IP IP 250mg 133.5mg 80mg q.s.
814 Sodium Feredetate,Folic Acid,Cyanocoba lamin Syrup Each 5ml Contains: SodiumFeredetate (Eq. to33 mg.elemental Iron) Folic Acid Cyanocobalamin Ina flavoured syrupy base Approved colour use BP IP IP 231mg 1.5mg 15mcg
815 Sodium Picosulfate Oral Solution BP Each 5 ml contains: Sodium Picosulfate In a flavoured sorbitol base Approved colour used BP 5 mg q.s.
816 Sodium Valproate & Valproic Acid Controlled ReleaseTablet Each film coated controlledrelease tablet contains: Sodium Valproate Valproic Acid (Both together correspond tosodium valproate) Excipients Approved colour used IP IP 133.5 mg 58 mg 200 mg q.s.
817 Sodium Valproate & Valproic Acid Controlled ReleaseTablet Each film coated controlledrelease tablet contains: Sodium Valproate Valproic Acid (Both together correspond tosodium valproate) Excipients Approved colour used IP IP 333 mg 145 mg 500 mg q.s.
818 Solifenacin Succinate Tablets IP Each film coated tablet contains: Solifenacin Succinate Excipients Approved colour used. IP 5mg q.s.
819 Spironolactone Tablets IP Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used IP 25mg q.s.
820 Spironolactone Tablets IP Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used IP 50mg q.s.
821 Spironolactone Tablets IP Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used IP 100mg q.s.
822 Sucralfate & Oxetacaine Oral suspension Each 10ml Contains:- Sucralfate Oxetacaine In palatable sorbitol Base Approved Colour Used. USP BP 1g. 20mg. q.s.
823 Sucralfate & Oxetacaine Suspension Each 5ml contains: Sucralfate Oxetacaine In a flavoured syrupyBase. Approved colour used. USP BP 500mg 10mg q.s.
824 Sucralfate & Oxetacaine Suspension Each 10ml contains: Sucralfate Oxetacaine In a flavoured palatable base Approved colour used IP BP 1g 10 mg q.s.
825 Sucralfate & Oxetacaine Suspension Each 5ml contains: Sucralfate Oxetacaine In a flavoured palatable base Approved colour used USP BP 1g 10 mg q.s.
826 Sucralfateand Oxetacaine Suspension Each 10ml contain: Sucralfate Oxetacaine In a flavoured sorbitol base Approved colour used IP BP IP BP
827 Sulfasalazine Gastro –Resistant Tablets IP Each enteric coated tablet contains: Sulfasalazine Excipients Approved colour used. IP 500mg q.s.
828 Sulfasalazine Gastro Resistant Tablets USP Each Enteric Coated Tablet Contains: Sulfasalazine Excipients Approved colour used USP 1000mg q.s.
829 Syrup of Iron, Folic Acid & Vitamin B12 with Minerals Each 15ml contains : Ferric Ammonium Citrate Cyanocobalamin Folic Acid Copper Sulphate Manganese Sulphate In a Flavoured Syrupybase. Approved colour Used. IP IP IP BP BP 160mg 7.5mcg 7.5mg 30mcg 30mcg q.s.
830 Syrup of vitamin iron ,folicacid, zinc with Cyanocobalamin. Each 15ml contains: FerricAmmonium citrate (equivalent to32.25mgElemental Iron) Cyanocobalamin Folic acid ZincSulphate (equivalent to7.5mg ofElement Zinc ) Flavored syrup base Approved Colour Used IP IP IP IP 150mg 15mcg 1.5mg 33mg q.s.
831 Tablets of Biotin, N-Acetyl L- Cysteine, Vitamins & Minerals Each film coated tablet contains: Biotin N-Acetyl L- Cysteine Calcium Pantothenate Sodium selenite eq.to elemental Selenium Cupric Oxide eq.to elemental Copper Zinc Oxide eq. to elemental Zinc Manganese Sulphate eq. to elemental Manganese Folic Acid Excipients Approved colour used. Appropriate overages of vitamins added to compensate Loss on storage For Therapeutic use only IP BP IP BP IP BP IP 10mg 50mg 100mg 65mcg 3mg 25mg 1mg 1mg q.s.
832 Tacrolimus cream Composition:- Tacrolimus Excipients IP 0.1%w/w q.s.
833 Tadalafil Tablet IP Each uncoated tablet contains: Tadalafil Excipients Approved colour used IP 10 mg q.s
834 Tadalafil Tablet IP Each uncoated tablet contains: Tadalafil Excipients Approved colour used IP 20 mg q.s
835 Tamsulosin Hydrochloride (MR) & Dutasteride Tablets Each film coated Tablet contains: Tamsulosin Hydrochloride (as modified release) Dutasteride Excipients Approved colour used. IP IP 0.4 mg 0.5 mg q.s.
836 Tamsulosin Hydrochloride Modified Release Tablets Each film coated Tablet contains: Tamsulosin Hydrochloride (as modified release) Excipients Approved colour used. IP 0.4mg q.s.
837 Tapentadol Tablets Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients Approved colour used IP 50 mg q.s.
838 Tapentadol Tablets Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients Approved colour used IP 100 mg q.s.
839 Telmisartan & AmlodipineTablets Each uncoated Bilayered Tablet Contains: Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Approved colour used IP IP 80mg 5mg q.s.
840 Telmisartan & AmlodipineTablets IP Each Uncoated Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Coloured Used IP IP 80mg 10mg q.s
841 Telmisartan & AmlodipineTablets IP Each Uncoated Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Colour Used. IP IP 40mg 5mg q.s.
842 Telmisartan & AmlodipineTablets IP Each Uncoated Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Approved Colour Used. IP IP 80mg 5mg q.s.
843 Telmisartan & AmlodipineTablets IP Each Uncoated Bilayered Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Colour Used. IP IP 40mg 5mg q.s.
844 Telmisartan & AmlodipineTablets IP Each Uncoated Bilayered Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Coloured Used. IP IP 80mg 10mg q.s
845 Telmisartan & Atorvastatin Tablets Each film coated Tablet Contains : Telmisartan Atorvastatin Calcium Equ. to Atorvastatin. Excipients Approved colour used. IP IP 40mg 10mg q.s.
846 Telmisartan & Chlorthalidone Tablets Each uncoated Bilayered Tablet contains: Telmisartan Chlorthalidone Excipients Approved colour used IP IP 40mg 12.5mg q.s.
847 Telmisartan & CilnidipineTablets Each Film coated Tablet Contains : Telmisartan Cilnidipine Excipients Approved colour used. IP IP 40mg 10mg q.s.
848 Telmisartan & Hydrochlorthiazide Tablet IP Each Uncoated Tablet Contains:- Telmisartan Hydrochlorothiazide Excipients Colour: Approved Coloured Used. IP IP 80mg 12.5mg q.s
849 Telmisartan & Metoprolol Succinate (ER) Tablets Each Uncoated Bilayered Tablet Contains: Telmisartan Metoprolol Succinate Equ. to Metoprolol Tartrate (as Extended Release ) Excipients Approved colour used IP IP IP 40mg 23.75 25mg q.s.
850 Telmisartan & Metoprolol Succinate (ER) Tablets Each uncoated bilayer tablet contain: Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used IP IP 40 mg 47.5 mg 50 mg q.s.
851 Telmisartan and Hydrochlorothiazid e TabletsIP Each Uncoated Tablet Contains:- Telmisartan Hydrochlorothiazide Excipients Colour: ApprovedColour Used. IP IP 40mg 12.5mg q.s.
852 Telmisartan Tablet IP Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used. IP 20mg q.s
853 Telmisartan Tablet IP Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used. IP 40mg q.s
854 Telmisartan Tablet IP Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used. IP 80mg q.s
855 Telmisartan, Amlodipine & Hydrochlorothiazid e Each uncoated bilayer tablet contain: Telmisartan Amlodipine Besylate Eq.to Amlodipine Hydrochlorothiazide Excipients Approved colour used IP IP IP 40 mg 5 mg 12.5 mg
856 Teneligliptin & Metformin Hydrochloride Tablets Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide hydrate Equivalent to Teneligliptin Metformin hydrochloride (As Extended release) Excipients Approved colour used IP 20 mg 1000 mg q.s.
857 Teneligliptin & Metformin hydrochloride Tablets Each uncoated by-layered tablets contains: Teneligliptin hydrobromide hydrat Equivalent to Teneligliptin Metformin hydrochloride (As Extended release) Excipients Approved colour used IP 20 mg 500 mg q.s.
858 Terbinafine Hydrochloride Cream IP Composition: Terbinafine Hydrochloride Preservatives Benzyl Alcohol In a Cream Base IP IP 1%w/w 1%w/w q.s.
859 Terbinafine hydrochloride Tablets IP Each filmcoated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients Approved colour used IP 250 mg q.s.
860 Terbinafine hydrochloride Tablets IP Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients Approved colour used IP 500 mg q.s.
861 Terbutaline , Bromhexine, Guaiphenesin and Menthol Syrup Each 5ml contains : Terbutaline Sulphate Bromhexinehydrochloride Guaiphenesin Menthol In a Flavoured SyrupyBase Approved colour used IP IP IP IP 1.25mg 2mg 50mg 0.5mg
862 Terbutaline Sulphate & Bromhexine Hydrochloride Syrup Each 5ml contains : Terbutaline Sulphate Bromhexine Hydrochloride In a Flavoured palatable base. Approved colour used IP IP 2.5mg 8mg q.s.
863 Terbutaline Sulphate & Choline Theophyllinate Syrup Each 5ml contains : Terbutaline Sulphate CholineTheophyllinate In a flavoured SyrupyBase. Approved colour Used. IP BP 1.25mg 50mg q.s.
864 Terbutaline Sulphate, Ambroxol HCl, Guaiphenesin & Menthol Expectorant Each 5ml contains : Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured SyrupyBase Approved colour used. IP IP IP IP 1.5mg 15mg 50mg 1.5mg q.s.
865 Terbutaline Sulphate, Ambroxol HCl, Guaiphenesin & Menthol Expectorant Each 5ml contains : Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured SyrupyBase Approved colour used. IP IP IP IP 1.5mg 15mg 50mg 1.5mg q.s.
866 Terbutaline Sulphate, Bromhexine HCL, Guaiphenesin & Menthol Syrup Each 5ml Contains Terbutaline Sulphate Equivalent to Terbutaline Bromhexine Hydrochloride Guaiphenesin Menthol In flavoured Syrupybase Approved colour used IP IP IP IP 1.25 mg 2 mg 50mg 0.5 mg q.s.
867 Terbutaline Sulphate, Guaiphenesin, Ambroxol Hydrochloride & Menthol Syrup Each 5ml contains : Terbutaline Sulphate Guaiphenesin Ambroxol Hydrochloride Menthol In a Flavoured syrupyBase Approved colour used IP IP IP IP 1.25mg 50mg 15mg 0.5mg q.s.
868 Thiamine Hydrochloride Tablets IP Each film coated Tablet Contains: Thiamine Hydrochloride Excipients Approved colour used IP 100mg q.s.
869 Thiamine Tablets IP Each uncoated Tablet Contains Thiamine Hydrochloride Excipients Colour :- Approved colour used IP 50mg q.s
870 Thiocolchicoside Capsules Each Hard Gelatin Capsule Contains : Thiocolchicoside Excipients Approved colour used in EmptyCapsule shells IP 4mg q.s.
871 Thymol, Menthol, Eucalyptol & Ethanol Mouthwash Composition : Thymol Menthol Eucalyptol Ethanol(95%) Approved Colour Used IP IP IP 0.06%w/v 0.04%w/v 0.09%w/v 21.6%v/v
872 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 12.5mcg q.s
873 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 25mcg q.s
874 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 50mcg q.s
875 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 75mcg q.s
876 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 100 mcg q.s
877 Ticagrelor Tablets Each film coated tablet contains: Ticagrelor Excipients Approved colour used IP 90mg q.s
878 Tolperisone Hydrochloride & Diclofenac Sodium Tablets Each Film coated Tablets Contains : Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved colour used IP IP 150mg 50mg q.s.
879 Tolperisone Hydrochloride & Paracetamol Tablet Each film coated Tablet Contains: Tolperisone hydrochloride Paracetamol Excipients Approved colour Used JP IP 150mg 325mg
880 Tolperisone Hydrochloride Sustained Release Tablet Each film coated sustained Release Tablet Contains: Tolperisone Hydrochloride Excipients Approved Colour Used JP 450mg
881 Tolperisone Hydrochloride Tablet Each film coated Tablet Contains: Tolperisone Hydrochloride Excipients Approved colour used JP 150mg q.s
882 Torsemide & Spironolactone Tablets Each uncoated tablet contains: Torsemide Spironolactone Excipients Approved colour used IP IP 5 mg 50 mg q.s.
883 Torsemide & Spironolactone Tablets Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used IP IP 10 mg 50 mg q.s.
884 Torsemide & Spironolactone Tablets Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used IP IP 20 mg 50 mg q.s.
885 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 10 mg q.s.
886 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 20 mg q.s.
887 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 5 mg q.s.
888 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 100 mg q.s.
889 Tramadol & ParacetamolTablet Each Film Coated Tablet Contains: Paracetamol Tramadol Hydrochloride Excipients Approved Colour Used IP IP 325mg 37.5mg q.s
890 Tramadol Hydrochloride Prolonged Release Tablet IP Each film coated sustainedrelease tablet contain: Tramadol Hydrochloride Excipients Approved colour used IP 100mg q.s
891 Tramadol Hydrochloride Tablet IP Each film coatedtablet contain: Tramadol Hydrochloride Excipients Approved colour used IP 100mg q.s
892 Tranexamic Acid & Ethamsylate Tablets Each film coated Tablet contains: Tranexamic Acid Ethamsylate Excipients Approved colour used. IP BP 250mg 250mg q.s.
893 Tranexamic Acid Tablets Each film coated Tablet Contains: Tranexamic Acid Excipients Colour : Approved Coloured Used BP 250mg q.s
894 Tranexamic Acid Tablets IP Each film coated Tablet Contains: Tranexamic Acid Excipients Colour : Approved Coloured Used IP 250mg q.s
895 Tranexamic Acid Tablets IP Each film coated Tablet Contains: Tranexamic Acid Excipients Approved Colour Used. IP 500mg
896 TranexamicAcid& Mefenamic Acid Tablets Each filmcoated tablets contains: Tranexamic Acid Mefenamic Acid Excipients Approved colour used IP IP 500 mg 250 mg q.s.
897 Tricholine Citrate & Sorbitol Solution Syrup Each 10 ml contains: Tricholine Citrate Sorbitol Solution (70%) (Non-Crystallising) Excipients Approved colour used. IP 0.55gm 7.150gm q.s.
898 Trifluoperazine Hydrochloride Tablets IP Each film coated Tablet contains: Trifluoperazine Hydrochloride Excipients Approved colour used IP 5mg q.s
899 Troxerutin, Calcium Dobesilate, Zinc, Phenylephrine, Lignocaine with Hydrocortisone Cream Composition : Troxerutin Calcium Dobesilate Monohydrate Equ. to Anhydrous Calcium Dobesilate Lignocaine Hydrochloride Hydrocortisone Acetate Zinc Oxide Phenylephrine Hydrochloride Cream Base BP BP IP IP IP IP 2.0%w/w 0.25%w/w 3.0%w/w 0.25%w/w 5.0%w/w 0.1%w/w q.s
900 Trypsin – Chymotrypsin Tablets Each enteric - coated tablet contains: 2,00,000 Armour Units of Enzymatic Activity* *Supplied by a purified Concentrate which has Specific Trypsin and Chymotrypsin Activity in a Ratio of Approximately Six to One. Excipients Approved colour used. 2,00,000 AU q.s.
901 Trypsin , Bromelain and Rutoside Trihydrate Tablets Each Enteric coated tablet contains: Trypsin Bromelain RutosideTrihydrate Excipients Approved colour used. BP BP 96mg 180mg 200mg q.s.
902 Trypsin- Chymotrypsin Tablets Each entericcoated Tablet contains: 1,00,000 Armour units of enzymaticactivity *Supplied by a purified concentrate which has specific Trypsin & Chymotrypsin activityin aratio of Approximately six to one. Excipients Approved colour used. q.s.
903 Trypsin-Chymotrypsin, Aceclofenac & Paracetamol Tablets Each film coated tablet contains: Aceclofenac Paracetamol Trypsin-Chymotrypsin Of enzyme activity (as enteric coated granules) Excipients Approved colour used. I.P. I.P. 100mg 325mg 150,000AU q.s.
904 Trypsin, Bromelain & Rutoside Trihydrate Tablets Each Enteric coatedTablet Contains:- Trypsin Bromelain RutosideTrihydrate Equivalent toRutoside (anhydrous) Excipients Approved colour used BP BP 48 mg 90 mg 100 mg q.s.
905 Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets Each Enteric coatedTablet Contains: Trypsin Bromelain Rutoside Trihydrate Diclofenac Sodium Excipients Approved Colour Used BP BP IP 48mg 90mg 100mg 50mg q.s.
906 Trypsin, Bromelain, Rutoside Trihydrate and Aceclofenac Tablets Each enteric coated Tablet contains : Trypsin Bromelain Rutoside Trihydrate Aceclofenac Excipients Approved colour used IP BP IP 48mg 90mg 100mg 100mg q.s
907 Urea, Lactic acid, Propylene Glycol & Liquid Paraffin Cream Composition : Urea Lactic Acid Propylene Glycol Liquid Paraffin Preservatives: Methyl Paraben Propyl Paraben Cream Base IP IP IP IP IP IP 10%w/w 10%w/w 10%w/w 10%w/w 0.16%w/w 0.04%w/w q.s
908 Ursodeoxycholic Acid Tablets IP Each filmcoated tablets contains: Ursodeoxycholic Acid Excipients Approved colour used IP 300 mg q.s.
909 Ursodeoxycholic Acid Tablets IP Each film coated tablets contains: Ursodeoxycholic Acid Excipients Approved colour used IP 150 mg q.s.
910 Ursodeoxycholic Oral Acid Suspension Each 5ml Contains : Ursodeoxycholic Acid Excipients Approved colour used IP 125mg q.s.
911 Ursodeoxycholic Oral Acid Suspension Each 5ml Contains : Ursodeoxycholic Acid Excipients Approved colour used IP 250mg q.s.
912 Vildagliptin & Metformin Hydrochloride Tablet Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Approved colour used IP 50 mg 500 mg q.s.
913 Vildagliptin & Metformin Hydrochloride Tablet Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Approved colour used IP 50 mg 1000 mg q.s.
914 Vildagliptin Tablet Each uncoatedtablet contains: Vildagliptin Excipients Approved colour used 50 mg q.s.
915 Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel Composition: Virgin Linseed Oil Diclofenac Diethylamine Equ. to Diclofenac Sodium Methyl Salicyclate Menthol Capsaicin Preservative : Benzyl Alcohol Gel Base BP IP IP IP USP IP 3.00%w/w 1.16%w/w 1.00%w/w 10.00%w/w 5.00%w/w 0.025%w/w 1.00%w/w q.s.
916 Vitamin B6, Nicotinamide, Vitamin B12 & Lysine Syrup Each 5ml contains : Pyridoxine Hydrochloride Nicotinamide Cyanocobalamin L-Lysine Hydrochloride Sorbitol Solution (70%) (Non-Crystallizing) Colour: Caramel IP IP IP USP IP 0.75mg 15mg 2mcg 37.5mg q.s
917 Vitamin D3 oral Drops Each ml contains: Cholecalciferol (Vitamin D3 as stabilized) In a flavoured syrupybase Approved colour used. IP 800IU q.s.
918 Vitamin D3 oral solution Each 5 ml contains: Cholecalciferol (In Nano Droplet form) In a flavoured sugar free syrupybase. Approved colour used. IP 60000IU q.s
919 Vitamin E Acetate & Levocarnitine Tablets Each film coated tablet contains: Tocopheryl Acetate (as 50% powder) L- Carnitine –L – Tartrate Eq. to Levocarnitine Appropriate overages added Excipients Approved colour used. IP USP 200mg 150mg q.s
920 Voglibose & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP 0.2 mg 500 mg q.s.
921 Voglibose & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP 0.3 mg 500 mg q.s.
922 Voglibose Dispersible Tablet IP Each uncoated tablet contains: Voglibose Excipients Approved colour used IP 0.2 mg q.s.
923 Voglibose Dispersible Tablet IP Each uncoated tablet contains: Voglibose Excipients Approved colour used IP 0.3 mg q.s.
924 Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP IP 0.3 mg 2 mg 500 mg q.s.
925 Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP IP 0.2 mg 1 mg 500mg q.s.
926 Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP IP 0.2 mg 2 mg 500mg q.s.
927 Voriconazole Tablet IP Each film coated Tablet Contains: Voriconazole Excipients Approved Colour Used. IP 200 mg q.s
928 Warfarin Sodium Tablets IP 1mg Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients ApprovedColour used IP 1mg q.s.
929 Warfarin Sodium Tablets IP 3mg Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used IP 3mg q.s.
930 Warfarin Sodium Tablets IP 5mg Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used IP 5mg q.s.
931 WhiteSoft Paraffin & Light Liquid Paraffin Cream Composition : White Soft Paraffin Light Liquid Paraffin Cream Base IP IP 13.2%w/w 10.2%w/w q.s
932 Zinc Acetate Oral Solution USP Each 5 ml contains: Zinc Acetate (as Dihydrate) Eq.to Elemental Zinc In a Mentholated Syrupy base. Approved colour used. USP 20mg q.s.
933 Zinc Acetate Syrup Each 5ml contains : Zinc Acetate (as Dihydrate) Equ. to Elemental Zinc In a Mentholated SyrupyBase. Approved Colour used. USP 20mg q.s.
934 Zinc Acetate Tablets Each Enteric coated Tablet Contains: Zinc Acetate(as dihydrate) Equ. toElemental Zinc Excipients Approved Colour Used USP 50mg q.s
935 Zinc gluconate Oral Solution Each 5ml contains: Zinc gluconate Eq. to elemental zinc In a flavoured syrupy base Approved colour used. USP 20mg q.s
936 ZincGluconate Suspension Each 5ml contains: Zinc Gluconate Equ. to Elemental Zinc In a flavoured SyrupyBase Colour: Ponceau 4R USP 20mg q.s
937 ZincSulphateOral Solution IP Each 5 ml Contains: Zinc Sulphate Equivalent to elemental zinc In a Flavoured palatable base Approved colour used IP 20 mg q.s.
logo

ASPO Pharmaceuticals is always dedicated to provide excellence in every product. Our commitment to quality, innovation, and customer happiness ensures that your business stands out in a competitive market.

Facebook-f Twitter Linkedin Instagram
Quick Links
Legal Links
Reach us

© Copyright 2022-2024. ASPO Pharmaceuticals. Designed by Hivends Info Solutions Pvt. Ltd
Call Us
Whatsapp